laboratory Blood Work

Hydrations LLC has teamed up with a nationally accredited laboratory to provide our clients with fast, reliable and affordable basic blood work solutions.  We offer our clients:

  • Fast Results
  • Lowest Prices
  • No Order/Script needed!
Time Sensitive Labs

Labs listed in Green require 10 hours of fasting before your blood draw
(You are allowed to have water, black coffee and take any medications while fasting.)
These labs should be scheduled between 10am and 12pm

Labs listed in Red require your blood to be drawn before 11am.

Lab Testing FAQ

What Payment Methods do you accept?
We accept Credit/Debit/FSA cards, Check or Cash

How do I get my results?
You will have the option of email, mail, faxed or pickup.

Will you go over my results with me?
No. We only provide the testing service. We do not review or make recommendation as far as which labs to get done, or what your results mean. You will need to share your results with your practitioner. (We will call you if you have a result that is considered “A Critical Lab value”)

What if I need a test not listed?
We are able to perform almost any blood test. (We do not do Urine, Saliva, Hair, etc at this location) Just contact us at (833) 372-9522 or HydrationsWellness@gmail.com with the test you need and we can provide you

Individual Test Directory
If you need a test not listed below, please contact us. In general we can offer all blood testing that does not require the sample to be frozen. You may find the 'Search' feature helpful in finding any specific test.
DescriptionTest Cost
ABO GRP AND RH TYPE
Test Details
AKA - Blood Type

ABO type and Rh are needed to identify candidates for Rh immune globulin and to assess the risk of hemolytic disease of the newborn.
$24
Absolute Lymphocyte Count
Test Details

Increased understanding of immunodeficiency syndrome and AIDS have identified the importance of absolute lymphocyte count in addition to the specific cell type such as CD4 lymphocytes. In pediatric ages up to 14 years old, acute infectious lymphocytosis is a clinical disorder, suspected to be of enterovirus-Coxsackie A subgroup that may have upper respiratory symptoms, fever, diarrhea and abdominal pain or a totally asymptomatic clinical course. Other conditions with absolute lymphocytosis are B. pertussis infection and lymphocytic leukemoid reaction. The most commonly known lymphocytosis with atypical morphology is due to cytomegalovirus and infectious mononucleosis. The malignant forms of absolute lymphocytosis are mostly due to lymphoproliferative disorders.

Includes

  • WBC
  • Absolute Lymphocytes
  • % Lymphocytes
  • % Reactive Lymphocytes

$33
ALBUMIN
Test Details

Serum albumin measurements are used in the monitoring and treatment of numerous diseases involving primarily the liver and kidney. Its main value lies in the follow-up therapy where improvement in the serum albumin level is the best sign of successful medical treatment. There may also be a loss of albumin in the gastrointestinal tract, in the urine by the damaged kidney or direct loss of albumin through the skin. More than 50% of patients with gluten enteropathy have depressed albumin. The only cause of increased albumin is dehydration; there is no naturally occurring hyperalbuminemia.

Reference Range(s)

3.6-5.1 g/dL

$18
Allergy, Gluten (IgE)
Test Details
This test is an allergen-specific IgE antibody test that quantifies an individual’s IgE response to gluten. It is an in vitro quantitative assay, which is intended to be used in conjunction with other clinical information to aid in the diagnosis of food allergy
Reference Range(s)
Positive or Negative
$27
ALLERGY PPROFILE (Molds)
Test Details

IgE allergy testing for:
Alternaria alternata (m6)
Aspergillus fumigatus (m3)
Cladosporium herbarum (m2)
Mucor racemosus (m4)
Penicillium notatum (m1)
Stemphylium botryosum (m10)


If you do not wish to have the entire panel done, you can get results for any specific allergen from the results list below. (Each individual test is $23)
$57
ALLERGY PROFILE (Foods)
Test Details

IgE allergy testing for:

Almond (f20)

Cashew Nut (f202)

Codfish (f3)

Cow's Milk (f2)

Egg White (f1)

Hazelnut (f17)

Peanut (f13)

Salmon (f41)

Scallop (f338)

Sesame Seed (f10)

Shrimp (f24)

Soybean (f14)

Tuna (f40)

Walnut (f256)

Wheat (f4)


If you do not wish to have the entire panel done, you can get results for any specific allergen from the results list below. (Each individual test is $23)
$129
ALLERGY PROFILE (Seafood)
Test Details

IgE allergy testing for:
Codfish (f3)
Crab (f23)
Lobster (f80)
Salmon (f41)
Shrimp (f24)
Tuna (f40)


If you do not wish to have the entire panel done, you can get results for any specific allergen from the results list below. (Each individual test is $23)
$58
ALLERGY PROFILE (Tree Nut)
Test Details

IgE allergy testing for:

Almond
Brazil Nut
Cashew Nut
Hazelnut
Macadamia Nut
Peanut
Pecan Nut
Pistachio
Walnut


If you do not wish to have the entire panel done, you can get results for any specific allergen from the results list below. (Each individual test is $23)
$78
ALLERGY PROFILE (Respiratory)
Test Details

IgE allergy testing for:

Alternaria alternata (a mold) (m6)
Aspergillus fumigatus (m3)
Bermuda grass (Cynodon dactylon) (g2)
Cat dander (e1)
Cladosporium herbarum (Hormodendrum) (m2)
Cockroach (i6)
Common Ragweed (short) (w1)
Cottonwood (Populous deltoides) (t14)
Dermatophagoides  farinae (d2)
Dermatophagoides pteronyssinus (d1)
Dog dander (e5)
Elm (t8)
Maple (box elder) (t1)
Maple leaf sycamore, London Plane (t11)
Mountain cedar (Juniperus sabinoides) (t6)
Mouse Urine Proteins (e72)
Mulberry (t70)
Oak (t7)
Pecan/Hickory (Carya soecue, pecan) (t22)
Penicillium notatum (m1)
Rough marsh elder (Iva) (w16)
Rough pigweed (Amaranthus retroflexus) (w14)
Russian thistle (Saltwort, Salsola kali) (w11)
Timothy grass (Phleum pratense) (g6)
Walnut (Juglans californica) (t10)
White ash (Fraxinus americana) (t15)


If you do not wish to have the entire panel done, you can get results for any specific allergen from the results list below. (Each individual test is $23)
$210
Alpha-Fetoprotein, Tumor Marker
Test Details

Elevation of serum AFP above values found in healthy individuals occurs in several malignant diseases, most notably nonseminomatous testicular cancer and primary hepatocellular carcinoma. AFP is not recommended as a screening procedure to detect cancer in the general population.

Reference Range(s)
 Male (ng/mL)Female (ng/mL)
<1 Month*0.5-16387.00.5-18964.0
1-11 Months0.5-28.30.5-77.0
1-3 Years0.5-7.90.5-11.1
>3 Years<6.1<6.1
$27
AMYLASE
Test Details
The major sources of amylase are the pancreas and the salivary glands. The most common cause of elevation of serum amylase is inflammation of the pancreas (pancreatitis). In acute pancreatitis, serum amylase begins to rise within 6-24 hours, remains elevated for a few days and returns to normal in 3-7 days. Other causes of elevated serum amylase are inflammation of salivary glands (mumps), biliary tract disease and bowel obstruction. Elevated serum amylase can also be seen with drugs (e.g., morphine) which constrict the pancreatic duct sphincter preventing excretion of amylase into the intestine.

Reference Range(s)

21-101 U/L
$21
ANA Screen,IFA, with Reflex to Titer and Pattern
Test Details
This immunofluorescence assay (IFA) is often ordered as part of an initial diagnostic evaluation of individuals with clinical suspicion of autoimmune diseases associated with antinuclear antibodies (ANAs). The American College of Rheumatology recommends IFA on human epithelial type 2 (HEp-2) cells as the gold standard method for ANA testing because of its overall high sensitivity [1]. ANAs are associated with several autoimmune diseases, such as systemic lupus erythematosus, systemic sclerosis, mixed connective tissue disease, polymyositis, primary biliary cholangitis, rheumatoid arthritis, juvenile rheumatoid arthritis, Sjogren syndrome, and autoimmune hepatitis. The laboratory evaluation for individuals with clinical suspicion of these autoimmune diseases often begins with an ANA screen. Knowing the ANA titer can be helpful in interpreting positive ANA results. A titer of at least 1:40 is considered positive, but low-positive titers are not uncommon in healthy individuals. Higher titers are generally associated with greater likelihood of autoimmune disease

Reference Range(s)

ANA Screen: Negative

ANA Titer:
<1:40 Negative

1:40-1:80 Low antibody level

>1:80 Elevated antibody level
$48
Anaplasma phagocytophilum Antibodies (IgG, IgM)
Test Details
Anaplasma phagocytophilum is a tick-borne agent that causes an acute febrile illness that often resembles Rocky Mountain spotted fever.

Reference Range(s)


A. phagocytophilum IgG<1:64
A. phagocytophilum IgM<1:20
$78
APOLIPOPROTEIN EVALUATION
Test Details

Apolipoprotein A1 is the primary protein associated with HDL cholesterol. Like HDL cholesterol, increased concentrations are associated with reduced risk of cardiovascular disease. Apolipoprotein B-100 is the primary protein associated with LDL cholesterol and other lipid particles. Like LDL cholesterol, increased concentrations are associated with increased risk of cardiovascular disease. The ratio of these two apolipoproteins correlates with risk of cardiovascular disease.

Apolipoprotein A1
Apolipoprotein B
Apolipoprotein B/A1 Ratio

Reference Range(s)

Apolipoprotein A1
Male≥115 mg/dL 
Female≥125 mg/dL 
Risk CategoryMaleFemale
Optimal≥115 mg/dL≥125 mg/dL
High<115 mg/dL<125 mg/dL

Cardiovascular event risk category cut points (optimal, high) are based on the AMORIS study, Walldius G et al. J Intern Med. 2004;255:188-205.

Apolipoprotein B<90 mg/dL
Risk Category 
Optimal<90 mg/dL
Moderate90-119 mg/dL
High≥120 mg/dL

Cardiovascular event risk category cut points (optimal, moderate, high) are based on National Lipid Association recommendations-Jacobson TA et al. J of Clin Lipid. 2015; 9: 129-169 and Jellinger PS et al. Endocr Pract. 2017;23(Suppl 2):1-87.

Apolipoprotein B/A1 Ratio

Male<0.77 
Female<0.63 
Risk CategoryMaleFemale
Optimal<0.77<0.63
Moderate0.77-0.950.63-0.78
High>0.95>0.78
$36
ARSENIC
Test Details
This assay is used to monitor exposure to arsenic, wellness, and therapy during treatment of chronic myelocytic leukemia.


Avoid seafood consumption for 48 hours prior to sample collection


Reference Range(s)

<23 mcg/L
$27
Babesia microti Antibodies (IgG, IgM), IFA
Test Details

Babesia serological testing is used to diagnose infection by the Babesia tick-borne protozoan. Infection may cause hemolytic anemia.

Reference Range(s)

Babesia microti Antibodies IgG<1:64
Babesia microti Antibodies IgM<1:20
$79
BETA-2 MICROTGLOBULIN
Test Details
Beta-2-microglobulin normally passes through the glomerulus into the proximal tubule where much of it is reabsorbed. Serum levels are therefore an index of glomerular function. When impaired, serum levels rise in inverse ratio to glomerular filtration rate. Increased amounts of beta-2-microglobulin are excreted in several renal disorders, e.g., Balkan nephropathy, heavy metal poisoning and renal tubular disease due to therapeutic agents. Serial levels of beta-2-microglobulin in serum and urine are used to evaluate transplant viability and anticipate rejection. Following a successful graft, serum levels decline toward normal. Increasing serum levels provide an early sign of rejection. Elevated levels are also noted in lymphproliferative disorders, neoplasms (malignant and benign), inflammatory disease, and autoimmune diseases such as systemic lupus erythematosus (SLE) and Sjögren's disease.



<2.51 mg/L
$33
Bilirubin, Total
Test Details
Measurement of the levels of bilirubin is used in the diagnosis and treatment of liver, hemolytic, hematologic, and metabolic disorders, including hepatitis and gallbladder obstructive disease.
$18
Bilirubin, Direct
Test Details
Measurement of the levels of bilirubin is used in the diagnosis and treatment of liver, hemolytic, hematologic, and metabolic disorders, including hepatitis and gall bladder obstruction. The assessment of direct bilirubin is helpful in the differentiation of hepatic disorders. The increase in total bilirubin associated with obstructive jaundice is primarily due to the direct (conjugated) fraction. Both direct and indirect bilirubin are increased in the serum with hepatitis.

Reference Range(s)

<0.2 mg/dL


$18
Bilirubin, Fractionated
Test Details
Measurement of the levels of bilirubin is used in the diagnosis and treatment of liver, hemolytic, hematologic, and metabolic disorders, including hepatitis and gall bladder obstructive disease.
Includes:
Bilirubin Direct
Bilirubin, Indirect
Bilirubin, Total
$28
C-REACTIVE PROTEIN (CRP)
Test Details
Increased CRP levels are found in inflammatory conditions including: bacterial infection, rheumatic fever, active arthritis, myocardial infarction, malignancies and in the post-operative state. This test cannot detect the relatively small elevations of CRP that are associated with increased cardiovascular risk.

<8.0 mg/L
$19
CA 125
Test Details
The CA 125 level can provide prognostic information in the follow-up management of patients with ovarian carcinoma. The assay should be used as an adjunctive test in the management of ovarian cancer patients. CA 125 is not recommended as a cancer screening procedure to detect cancer in the general population.

Reference Range(s)

<35 U/mL
$24
CA 15-3
Test Details
CA 15-3 may be useful for monitoring patients with metastatic breast cancer and certain ovarian cancers. The CA 15-3 values from sequential samples have a high correlation with the clinical course in most patients with metastatic breast cancer.

Reference Range(s)


<32 U/mL
$28
CA 19-9
Test Details
A large percentage of patients with gastrointestinal tumors (such as pancreatic, liver, gastric, colorectal tumors) and some other malignancies have been shown to have elevated serum CA 19-9 levels. Serum CA 19-9 levels may be useful for monitoring disease activity or predicting relapse following treatment. CA 19-9 should not be used as a screening test.

Reference Range(s)


<34 U/mL
$26
CA 27.29
Test Details
CA 27.29 may be useful for monitoring patients for metastatic breast cancer.

Reference Range(s)

<38 U/mL
$29
Cadmium
Test Details
Cadmium is a naturally occurring element that is mined and used in industrial production because of its durability. Excessive cadmium exposure can damage lungs, kidneys, and the digestive tract.
Adults, Non-Smokers≤1.7 mcg/L
Adults, Smokers≤5.0 mcg/L
OSHA Reference Range≤5.0 mcg/L
Toxic ConcentrationEarly signs of toxicity have been observed at 30 mcg/L
$42
CALCIUM, IONIZED
Test Details

Ionized calcium represents the true "bioavailable" calcium in the circulation. In situations where the total calcium is normal but does not fit the clinical picture, e.g. , hyperparathyroidism, a determination of the ionized calcium will, many times, show an elevation in the "bioavailable" calcium component. This may be due to alterations in protein concentrations, especially albumin, that binds most of the calcium in the circulation.

Reference Range(s

<8 MonthsNot established
8 Months-10 Years4.9-5.4 mg/dL
11-17 Years4.8-5.3 mg/dL
Adult4.8-5.6 mg/dL
$26
CALCIUM
Test Details

Serum calcium is involved in the regulation of neuromuscular and enzyme activity, bone metabolism and blood coagulation. Calcium blood levels are controlled by a complex interaction of parathyroid hormone, vitamin D, calcitonin and adrenal cortical steroids. Calcium measurements are useful in the diagnosis of parathyroid disease, some bone disorders and chronic renal disease. A low level of calcium may result in tetany.

Reference Range(s)

Male (mg/dL)Female (mg/dL)
<1 month:8.4-10.68.4-10.6
1-11 months:8.7-10.58.7-10.5
1-3 years:8.5-10.68.5-10.6
4-19 years:8.9-10.48.9-10.4
20-49 years:8.6-10.38.6-10.2
>49 years:8.6-10.38.6-10.4
$18
CARBON DIOXIDE
Test Details

Measurements are used in the diagnosis and treatment of numerous potentially serious disorders associated with changes in body acid-base balance.

Reference Range(s)

Carbon Dioxide20-32 mmol/L
Carbon Dioxide (High Altitude)18-30 mmol/L
$18
CARDIAC CRP (High Sensitivity)
Test Details

Useful in predicting risk for cardiovascular disease.

≤17 yearsNot established
>17 yearsOptimal <1.0 mg/L

Jellinger PS et al. Endocr Pract. 2017;23(Suppl 2):1-87.

For ages >17 years

hs-CRP (mg/L)Risk According to AHA/CDC Guidelines
<1.0Lower relative cardiovascular risk.
1.0-3.0Average relative cardiovascular risk.
3.1-10.0Higher relative cardiovascular risk. Consider retesting in 1 to 2 weeks to exclude a benign transient elevation in the baseline CRP value secondary to infection or inflammation.
>10.0Persistent elevation, upon retesting, may be associated with infection and inflammation.
$26
Cardio IQ Lipid Panel
Test Details
This is the most common Lipid Panel. Components include those useful in the detection, classification, and monitoring of patients with hyperlipidemia.


Cardio IQ® Cholesterol, Total
Cardio IQ® HDL Cholesterol
Cardio IQ® Triglycerides
Cardio IQ® Non-HDL and Calculated Components
$28
Cardio IQ Direct LDL
Test Details
LDL Cholesterol is referred to as the "bad" cholesterol. Interpretive ranges are based on the guidelines of the National Cholesterol Education Program (NCEP).

Reference Range(s)
<20 Years<110 mg/dL
≥20 Years<100 mg/dL
$26
Cardio IQ HGB A1C
Test Details
To assist with control of blood glucose levels, the American Diabetes Association (ADA) has recommended glycated hemoglobin testing (HbA1c) twice a year for patients with stable glycemia, and quarterly for patients with poor glucose control. Interpretative ranges are based on ADA guidelines.
Reference Range(s)
<5.7 % of total hemoglobin
$28
Cardio IQ High Sensitivity CRP
Test Details
Useful in predicting risk of cardiovascular disease..
Reference Range(s)
hs-CRP (mg/L)Risk According to AHA/CDC Guidelines
<1.0Lower relative cardiovascular risk.
1.0-3.0Average relative cardiovascular risk.
3.1-10.0Higher relative cardiovascular risk.
Consider retesting in 1 to 2 weeks to exclude a benign transient elevation in the baseline CRP value secondary to infection or inflammation.
>10.0Persistent elevation, upon retesting, may be associated with infection and inflammation.
$32
Cardio IQ Lipoprotein Fract, Ion Mobility
Test Details
There is a correlation between increased risk of premature heart disease with decreasing size of LDL particles. Ion mobility offers the only direct measurement of lipoprotein particle size and concentration for each lipoprotein from HDL3 to large VLDL.
Includes:
LDL Particle Number
LDL Small
LDL Medium
HDL Large
LDL Pattern
LDL Peak Size
$48
CEA
Test Details
Increased serum CEA levels have been detected in persons with primary colorectal cancer and in patients with other malignancies involving the gastrointestinal tract, breast, lung, ovarian, prostatic, liver and pancreatic cancers. Elevated serum CEA levels have also been detected in patients with nonmalignant disease, especially patients who are older or who are smokers. CEA levels are not useful in screening the general population for undetected cancers. However, CEA levels provide important information about patient prognosis, recurrence of tumors after surgical removal, and effectiveness of therapy.


Reference Range(s)


Non-Smoker<2.5ng/mL
Smoker<5.0ng/mL
$28
Chromium
Test Details
This assay is useful to monitor exposure to chromium, progress of medical treatment or determine nutritional status.

≤1.2 mcg/L
$34
Cobalt
Test Details
Cobalt is part of our diet. Approximately 85% of absorbed cobalt is excreted in the urine and the remainder eliminated in stool. Toxicity may occur in select industrial environments. Cobalt is not mined in the United States so primary supplies are imported.


≤1.8 mcg/L
$39
COENZYME Q-10
Test Details
CoQ10 testing is useful for individuals on statin therapy who may or may not be experiencing myalgia symptoms, hypercholesterolemic individuals, and asymptomatic individuals at risk for vascular disease who may have low ApoA1 and/or HDL levels.

>0.35 ug/mL
$33
COPPER
Test Details
Copper is an essential element that is a cofactor of many enzymes. Copper metabolism is disturbed in Wilson's disease, Menkes disease, primary biliary cirrhosis, and Indian childhood cirrhosis. Copper concentrations increase in acute phase reactions and during the third trimester of pregnancy. Copper concentrations are decreased with nephrosis, malabsorption, and malnutrition. Copper concentrations are also useful to monitor patients, especially preterm newborns, on nutritional supplementation. Results of copper are often interpreted together with ceruloplasmin.

≤5 Months38-104 mcg/dL
6-11 Months24-152 mcg/dL
12 Months-23 Months76-193 mcg/dL
1-3 Years87-187 mcg/dL
4-5 Years56-191 mcg/dL
6-9 Years117-181 mcg/dL
10-13 Years87-182 mcg/dL
14-17 Years75-187 mcg/dL
≥18 Years70-175 mcg/dL
$34
CORTISOL, TOTAL
Test Details

Cortisol is increased in Cushing's Disease and decreased in Addison's Disease (adrenal insufficiency).

0-3 Days (infants)
Premature (31-35 Weeks)a.m. or p.m. ≤15.0 mcg/dL
Terma.m. or p.m. ≤14.0 mcg/dL
4 Days-1 Montha.m. or p.m. Not established
2-11 Monthsa.m. 3.0-23.0 mcg/dL
p.m. Not established
1-17 Yearsa.m. 3.0-25.0 mcg/dL
p.m. 3.0-17.0 mcg/dL
Adult 8 a.m. (7-9 a.m.) specimen4.0-22.0 mcg/dL
Adult 4 p.m. (3-5 p.m.) specimen3.0-17.0 mcg/dL
$22
CORTISOL, A.M
Test Details
Cortisol is increased in Cushing's Disease and decreased in Addison's Disease (adrenal insufficiency). (Must be collected between 7am and 9am)
Reference Range(s)
0-3 Days (infants)
  Premature (31-35 Weeks)≤15.0 mcg/dL
 Term≤14.0 mcg/dL
4 Days-1 MonthNot established
2-11 Months 8 a.m. (7-9 a.m.)3.0-23.0 mcg/dL
1-17 Years 8 a.m. (7-9 a.m.)3.0-25.0 mcg/dL
>17 Years 8 a.m. (7-9 a.m.)4.0-22.0 mcg/dL
$22
Complete Blood Count (CBC w/DIFF/PLT)
Test Details

A complete blood count is used as a screening test for various disease states to include: anemia, leukemia and inflammatory processes.

Includes:

  • WBC
  • RBC
  • Hemoglobin
  • Hematocrit
  • MCV
  • MCH
  • MCHC
  • RDW
  • Platelet Count
  • MPV and Differential
  • (Absolute and Percent - Neutrophils, Lymphocytes, Monocytes, Eosinophils, and Basophils)


If abnormal cells are noted on a manual review of the peripheral blood smear or if the automated differential information meets specific criteria, a full manual differential will be performed.

$19
Comprehensive Metabolic Panel (CMP)
Test Details

  • Albumin
  • Albumin/Globulin Ratio (calculated)
  • Alkaline Phosphatase
  • ALT
  • AST
  • BUN/Creatinine Ratio (calculated)
  • Calcium
  • Carbon Dioxide
  • Chloride
  • Creatinine with GFR Estimated
  • Globulin (calculated)
  • Glucose
  • Potassium
  • Sodium
  • Total Bilirubin
  • Total Protein
  • Urea Nitrogen
$20
C-PEPTIDE
Test Details
C-Peptide is useful in the evaluation of pancreatic beta cell function (e.g., helping distinguish type 1 from type 2 diabetes mellitus, or monitoring patients who have received islet cell or pancreatic transplants) and for determining the source of insulin in patients with hyperinsulinemic hypoglycemia (e.g., distinguishing insulin-secreting tumors from exogenous insulin administration). It is also sometimes measured as an additional means (more resistant to hemolysis than is insulin itself) for evaluating glucose tolerance tests.

0.80-3.85 ng/mL
$41
D-DIMER, Quantitative
Test Details
D-Dimer is one of the measurable by-products of activation of the fibrinolytic system. Quantitation of D-Dimer assesses fibrinolytic activation and intravascular thrombosis. D-Dimer is of particular value in excluding the diagnosis of venous thromboembolism among patients at high risk.



<0.50 mcg/mL FEU
$107
DHEA-SULFATE
Test Details

DHEA-S is the sulfated form of DHEA and is the major androgen produced by the adrenal glands. This test is used in the differential diagnosis of hirsute or virilized female patients and for the diagnosis of isolated premature adrenarche and adrenal tumors. About 10% of hirsute women with Polycystic Ovarian Syndrome (PCOS) have elevated DHEA-S but normal levels of other androgens.

AgeMale
(mcg/dL)		Female
(mcg/dL)
<1 Month≤31615-261
1-6 Months≤58≤74

7-11 Months

≤26≤26
1-3 Years≤15≤22
4-6 Years≤27≤34
7-9 Years≤91≤92
10-13 Years≤138≤148
14-17 Years38-34037-307
18-21 Years24-53751-321
22-30 Years85-69018-391
31-40 Years106-46423-266
41-50 Years70-49519-231
51-60 Years38-3138-188
61-70 Years24-24412-133
≥71 Years5-2537-177
$26
Dihydrotestosterone (DHT)
Test Details

Dihydrotestosterone (DHT) is a potent androgen derived from testosterone via 5-Alpha-Reductase activity. 5-Alpha-Reductase deficiency results in incompletely virilized males (phenotypic females). This diagnosis is supported by an elevated ratio of testosterone to DHT.

Female≤20 ng/dL
Male12-65 ng/dL
$49
Ehrlichia chaffeensis (IgG, IgM)
Test Details

Human Monocytic Ehrlichiosis (HME) is a tick-borne infection caused by Ehrlichiachaffeensis. Infections range in severity from asymptomatic to life-threatening, especially in patients who are immunocompromised.

Reference Range(s)

E. chaffeensis IgG<1:64
E. chaffeensis IgM<1:20
$53
Epstein-Barr Virus (EBV) ANTIBODY PANEL
Test Details

Primary infection by EBV causes infectious mononucleosis, usually a self-limiting disease in children and young adults. Infection with EBV can cause lymphoproliferative disorders including tumors. VCA-IgM is typically detectable at clinical presentation, then declines to undetectable levels within a month in young children and within 3 months in other individuals. VCA-IgG is typically detectable at clinical presentation, and persists for life. EBNA IgG typically appears during convalescence (3-4 months after clinical presentation) and remains detectable for life.

Reference Range(s)

Epstein-Barr Virus VCA Antibody (IgM)
U/mLInterpretation
<36.00Negative
36.00-43.99Equivocal
>43.99Positive

Epstein-Barr Virus VCA Antibody (IgG)
U/mLInterpretation
<18.00Negative
18.00-21.99Equivocal
>21.99Positive

Epstein-Barr Virus Nuclear Antigen (EBNA) Antibody (IgG)
U/mLInterpretation
<18.00Negative
18.00-21.99Equivocal
>21.99Positive

 

$37
Epstein-Barr Virus Early Antigen D Antibody (IgG)
Test Details
Primary infection by EBV causes infectious mononucleosis, usually a self-limiting disease in children and young adults. Infection with EBV can cause lymphoproliferative disorders including tumors. IgG recognizing Early Antigen D typically appears within a month after clinical presentation and is transient, lasting only 3-4 months. Persistently elevated levels suggest reactivation or persistence of EBV infection.

Reference Range(s)


U/mLInterpretation
<9.00Negative
9.00-10.99Equivocal
>10.99Positive
$47
ESTRADIOL
Test Details
Measuring the circulating levels of estradiol is important for assessing the ovarian function and monitoring follicular development for assisted reproduction protocols. Estradiol plays an essential role throughout the human menstrual cycle. Elevated estradiol levels in females may also result from primary or secondary ovarian hyperfunction. Very high estradiol levels are found during the induction of ovulation for assisted reproduction therapy or in pregnancy. Decreased estradiol levels in females may result from either lack of ovarian synthesis (primary ovarian hypofunction and menopause) or a lesion in the hypothalamus-pituitary axis (secondary ovarian hypofunction). Elevated estradiol levels in males may be due to increased aromatization of androgens, resulting in gynecomastia.

Reference Range(s)




Female
  Follicular Phase19-144 pg/mL
  Mid-Cycle64-357 pg/mL
  Luteal Phase56-214 pg/mL
  Postmenopausal≤31 pg/mL
Male≤39 pg/mL
$28
ESTRADIOL, Ultra-Sensitive
Test Details
Diagnostic applications of estradiol assays include assessment of ovarian function in a wide variety of situations (menstrual disorders, precocious or delayed puberty, assisted reproduction protocols). For men, estradiol measurement may be useful in the evaluation of gynecomastia.
Adult Reference Ranges for Estradiol, Ultrasensitive
Males≤29 pg/mL
Females 
  Follicular Phase39-375 pg/mL
  Luteal Phase48-440 pg/mL
  Postmenopausal Phase≤10 pg/mL
$56
ESTROGEN, TOTAL
Test Details

Estrogens are secreted by the gonads, adrenal glands, and placenta. Total estrogens provide an overall picture of estrogen status for men and women.

Reference Range(s)

Adult Female 
   Follicular Phase (1-12 days)90-590 pg/mL
   Luteal Phase130-460 pg/mL
   Postmenopausal50-170 pg/mL
Adult Male60-190 pg/mL
$36
ESTRONE
Test Details

Estrone is primarily derived from metabolism of androstenedione in peripheral tissues, especially adipose tissues. Individuals with obesity have increased conversion of androstenedione to Estrone leading to higher concentrations. In addition, an increase in the ratio of Estrone to Estradiol may be useful in assessing menopause in women.

Reference Range(s)

Adult  
Male≤68pg/mL
Female  
  Follicular Stage10-138pg/mL
  Luteal Stage16-173pg/mL
  Postmenopausal≤65pg/mL


Pediatric		Male
(pg/mL)		Female
(pg/mL)
Pre-pubertal (1-9 Years)<10≤34
10-11 Years≤12≤72
12-14 Years≤28≤75
15-17 Years≤64≤188
$29
FERRITIN
Test Details

Useful in the diagnosis of hypochromic, microcytic anemias. Decreased in iron deficiency anemia and increased in iron overload.

Reference Range(s)

Pediatric
<4 DaysNot established
4-14 Days100-717 ng/mL
15 Days-5 Months14-647 ng/mL
6-11 Months8-182 ng/mL

Male
1-4 Years5-100 ng/mL
5-13 Years14-79 ng/mL
14-15 Years13-83 ng/mL
16-18 Years11-172 ng/mL
19-59 Years38-380 ng/mL
>59 Years24-380 ng/mL

Female
1-4 Years5-100 ng/mL
5-13 Years14-79 ng/mL
14-18 Years6-67 ng/mL
19-40 Years16-154 ng/mL
41-60 Years16-232 ng/mL
>60 Years16-288 ng/mL
$23
FIBRINOGEN ACTIVITY
Test Details

Fibrinogen is essential for the formation of a blood clot. Deficiency can produce mild to severe bleeding disorders.

Reference Range(s)

175-425 mg/dL

$33
FOLATE
Test Details

Folic acid deficiency is common in pregnant women, alcoholics, in patients whose diets do not include raw fruits and vegetables, and in people with structural damage to the small intestine. The most reliable and direct method of diagnosing folate deficiency is the determination of folate levels in both erythrocytes and serum. Low folic acid levels, however, can also be the result of a primary vitamin B12 deficiency that decreases the ability of cells to take up folic acid.

Reference Range(s)

≤4 yearsNot established
5-9 years>7.1 ng/mL
10-17 years>8.0 ng/mL
  
≥18 years 
  Low<3.4 ng/mL
  Borderline3.4-5.4 ng/mL
  Normal>5.4 ng/mL
$23
FSH & LH
Test Details

FSH and LH are secreted by the anterior pituitary in response to gonadotropin-releasing hormone (GNRH) secreted by the hypothalamus. In both males and females, FSH and LH secretion is regulated by a balance of positive and negative feedback mechanisms involving the hypothalamic-pituitary axis, the reproductive organs, and the pituitary and sex steroid hormones. FSH and LH play a critical role in maintaining the normal function of the male and female reproductive systems. Abnormal FSH levels with corresponding increased or decreased levels of LH, estrogens, progesterone, and testosterone are associated with a number of pathological conditions. Increased FSH levels are associated with menopause and primary ovarian hypofunction in females and primary hypogonadism in males. Decreased levels of FSH are associated with primary ovarian hyper-function in females and primary hypergonadism in males. Normal or decreased levels of FSH are associated with polycystic ovary disease in females. In males, LH is also called interstitial cell-stimulating hormone (ICSH). Abnormal LH levels with corresponding increased or decreased levels of FSH, estrogens, progesterone, and testosterone are associated with a number of pathological conditions. Increased LH levels are associated with menopause, primary ovarian hypofunction, and polycystic ovary disease in females and primary hypo-gonadism in males. Decreased LH levels are associated with primary ovarian hyperfunction in females and primary hyper-gonadism in males.

Reference Range(s)

FSH
Male1.6-8.0mIU/mL
Female  
  Follicular Phase2.5-10.2mIU/mL
  Mid-Cycle Peak3.1-17.7mIU/mL
  Luteal Phase1.5- 9.1mIU/mL
  Postmenopausal  23.0-116.3 mIU/mL

LH
Male  
18-59 Years1.5-9.3mIU/mL
≥60 Years1.6-15.2mIU/mL
Female  
  Follicular Phase1.9-12.5mIU/mL
  Mid-Cycle Peak8.7-76.3mIU/mL
  Luteal Phase0.5-16.9mIU/mL
  Postmenopausal10.0-54.7mIU/mL
$26
FTA- ABS
Test Details
The FTA-ABS is a specific treponemal assay to detect antibody to T. pallidum. The FTA-ABS becomes reactive 4-6 weeks after infection. Unlike the nontreponemal tests, once the FTA-ABS test becomes reactive, it will remain reactive for many years. Since the reactivity found with the FTA-ABS does not indicate response to therapy, it is not suitable for monitoring treatment. The FTA-ABS test does not distinguish between syphilis and other treponematoses such as yaws, pinta and bejil.

Reference Range(s)

non-reactive
$41
Gamma Glutamyl Transferase (GGT)
Test Details

Elevated GGT is found in all forms of liver disease. Measurement of GGT is used in the diagnosis and treatment of alcoholic cirrhosis, as well as primary and secondary liver tumors. It is more sensitive than alkaline phosphatase, the transaminases, and leucine aminopeptidase in detecting obstructive jaundice, cholangitis, and cholecystitis. Normal levels of GGT are seen in skeletal diseases; thus, GGT in serum can be used to ascertain whether a disease, suggested by elevated alkaline phosphatase, is skeletal or hepatobiliary.

Reference Range(s)

Male (U/L)Female (U/L)
<6 Months12-12215-132
6-11 Months ≤39 ≤39
1-12 Years3-223-22
13-15 Years8-327-18
16-19 Years9-316-26
20-29 Years3-703-40
30-39 Years3-903-50
40-54 Years3-95 
40-49 Years 3-55
50-59 Years 3-70
55-59 Years3-85 
≥60 Years3-703-65
$19
GAST Parietal Cell AB
Test Details
Gastric Parietal Cell Antibodies are found in 90% of patients with pernicious anemia. They are also found in autoimmune chronic atrophic gastritis preceding pernicious anemia. The antigenic target is the H+/K+ ATPase gastric proton pump responsible for parietal cell acid generation in the stomach.

Reference Range(s)
≤20.0 UNegative
20.1-24.9 UEquivocal
≥25.0 UPositive
$74
Glucose-6-Phosphate Dehydrogenase (G-6-PD)
Test Details
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzyme deficiency in the world, affecting an estimated 400 million people worldwide [1]. It is more common in people of African, Mediterranean, and Asian descent. G6PD deficiency is an X-linked genetic disorder and, in general, affects males more than females. Severity ranges from mild to severe subtypes. Newborns with G6PD deficiency may have prolonged and more pronounced neonatal jaundice than other newborns. Adults with G6PD deficiency may have episodes of acute hemolytic anemia, and symptoms may include jaundice, fatigue, splenomegaly, and dark urine. Episodes may be induced by illness (infections), certain foods (fava beans), and particular medications (for example some sulfonamides and antimalarial drugs)[2]; therefore, some precautions may be recommended to avoid offending triggers.

Quantitative Glucose-6-Phosphate Dehydrogenase is an assay that measures the G6PD enzyme level. A low value may indicate G6PD deficiency (as opposed to values either within or above the reference range). [Perkins[3]] has found that some females with G-6-PD deficiency have difficulty in carrying a pregnancy to term. Erythrocytic G-6-PD appears to be sensitive to the endocrine changes associated with pregnancy. [Vergnes and Clerc [4]] found that 65% of their patients showed a significant fall in the G-6-PD activity in the later months of pregnancy with return to normal after delivery. Of note, as reticulocytes have higher G6PD activity than mature erythrocytes, if the blood sample is collected just after an acute hemolytic episode, G6PD activity levels can be falsely normal [5]. Therefore, if G6PD deficiency is suspected, consider repeating the test. Molecular genetic testing may also be indicated in cases where the disorder is suspected, or where there is a family history of G6PD deficiency, as enzyme activity may be normal in heterozygous females.

Reference Range(s)

7.0-20.5 U/g Hgb
$37
hCG, Total, Qualitative
Test Details

This test should be used only to determine pregnancy.

Reference Range(s)

Males and Non-Pregnant FemalesNegative
Pregnant FemalesPositive
$32
hCG, Qual. W/Reflex to Quant.
Test Details
This test should be used only to determine pregnancy.  If positive, then a quantitative analysis is performed

Reference Range(s)
Males and Non-Pregnant FemalesNegative
Pregnant FemalesPositive
Quantitative Reference Range
Male<5 mIU/mL
Female
  Non-pregnant or Premenopausal<5 mIU/mL
  Postmenopausal<10 mIU/mL
$54
HEAVY METALS (B)
Test Details

Useful in the diagnosis of toxicity due to Arsenic, Lead or Mercury.

Reference Range(s)

Arsenic, Blood<23 mcg/L

Whole Blood Arsenic level >100 mcg/L is indicative of acute/chronic exposure. Urine is usually the best specimen for the analysis of arsenic in body fluids. Blood levels tend to be low even when urine concentrations are high.

Lead (Venous)

Birth-6 years<5 mcg/dL
>6 years<5 mcg/dL

Blood lead levels in the range of 5-9 mcg/dL have been associated with adverse health effects in children aged 6 years and younger. Patient management varies by age and CDC Blood Lead Level range. Refer to the CDC website regarding Lead Publications/Case Management for recommended interventions.

Mercury, Blood≤10 mcg/L
$48
Hemoglobin A1c
Test Details
To assist with control of blood glucose levels, the American Diabetes Association (ADA) has recommended glycated hemoglobin testing (HbA1c) twice a year for patients with stable glycemia, and quarterly for patients with poor glucose control. Interpretative ranges are based on ADA guidelines.

Reference Range(s)

<5.7 % of total hemoglobin
$23
Hepatic Function Panel
Test Details

Includes:

  • Total Protein
  • Albumin
  • Globulin (calculated)
  • Albumin/Globulin Ratio (calculated)
  • Total Bilirubin
  • Direct Bilirubin
  • Indirect Bilirubin (calculated)
  • Alkaline Phosphatase
  • AST
  • ALT
$19
HEPATITIS Panel
Test Details
This panel provides information on infection and the immune response to hepatitis A virus (HAV), hepatitis B virus (HBV), and hepatitis C virus (HCV), the 3 most common causes of viral hepatitis in the United States. In patients with unexplained elevated liver enzyme levels, this panel may be helpful in evaluating etiology for these viral hepatitides [1-4].

This panel includes 5 tests with reflexes: total HAV antibody, qualitative hepatitis B surface antibody (HBsAb), hepatitis B surface antigen (HBsAg) with reflex confirmation, total hepatitis B core antibody (HBcAb), and HCV antibody with reflex to HCV RNA quantitative real-time PCR.

Includes:

Hepatitis A Antibody, Total
Hepatitis B Surface Antibody, Qualitative
Hepatitis B Surface Antigen with Reflex Confirmation
Hepatitis B Core Antibody, Total
Hepatitis C Antibody with Reflex to HCV, RNA, Quantitative, Real-Time PCR
$154
Homocysteine
Test Details

An elevated concentration of homocysteine is an independent risk factor for cardiovascular disease. When used in conjunction with methylmalonic acid (MMA), these tests are useful to diagnose and monitor vitamin B12 (cobalamin) and folic acid deficiency and are often useful in evaluating macrocytosis (an elevated MCV, an erythrocytic index).

Reference Range(s):

Male<11.4 umol/L
Female<10.4 umol/L
$36
IMMUNOGLOBULINS
Test Details

Elevations of IgG, A and/or M are seen in generalized hypergammaglobulinemia, chronic inflammatory conditions and in lymphoproliferative diseases such as multiple myeloma, lymphoma and leukemias. Decreased levels are found in immunodeficiency states, generalized hypogammaglobulinemia and in unrecognized pediatric patients.

Reference Range(s)

IgA, Serum

Cord Blood1-3 mg/dL
1-28 days2-40 mg/dL
1-3 months3-40 mg/dL
4-6 months7-47 mg/dL
7-11 months12-53 mg/dL
1 year20-73 mg/dL
2 years20-99 mg/dL
3-5 years22-140 mg/dL
6-8 years31-180 mg/dL
9-11 years33-200 mg/dL
12-16 years36-220 mg/dL
17-60 years47-310 mg/dL
≥61 years70-320 mg/dL


IgG, Serum

Cord Blood600-1600 mg/dL
1-28 days250-600 mg/dL
1-3 months200-600 mg/dL
4-6 months160-590 mg/dL
7-11 months160-800 mg/dL
1 year280-1040 mg/dL
2 years330-1120 mg/dL
3-5 years390-1360 mg/dL
6-8 years440-1470 mg/dL
9-11 years480-1530 mg/dL
12-16 years500-1590 mg/dL
17-60 years600-1640 mg/dL
≥61 years600-1540 mg/dL


IgM, Serum

Cord Blood6-25 mg/dL
1-28 days10-50 mg/dL
1-3 months10-72 mg/dL
4-6 months12-86 mg/dL
7-11 months13-120 mg/dL
1 year23-130 mg/dL
2 years25-135 mg/dL
3-5 years26-150 mg/dL
6-8 years25-150 mg/dL
9-11 years40-160 mg/dL
12-16 years41-170 mg/dL
≥17 years50-300 mg/dL
$41
IMMUNOGLOBULINS, IgA
Test Details
Increased IgA is associated with monoclonal IgA myeloma, respiratory and gastrointestinal infections, and malabsorption; decreased IgA is found in selective IgA deficiency and in ataxia telangiectasia.

Reference Range(s)

IgA, Serum
Cord Blood1-3 mg/dL
1-28 days2-40 mg/dL
1-3 months3-40 mg/dL
4-6 months7-47 mg/dL
7-11 months12-53 mg/dL
1 year20-73 mg/dL
2 years20-99 mg/dL
3-5 years22-140 mg/dL
6-8 years31-180 mg/dL
9-11 years33-200 mg/dL
12-16 years36-220 mg/dL
17-60 years47-310 mg/dL
≥61 years70-320 mg/dL
$24
IMMUNOGLOBULINS, IgG
Test Details
Increased IgG is associated with acute and chronic inflammations, monoclonal IgG myeloma, autoimmune diseases; decreased IgG is found in selective IgG deficiency, Bruton's Disease, and acquired immune deficiency.

Reference Range(s)

IgG, Serum
Cord Blood600-1600 mg/dL
1-28 days250-600 mg/dL
1-3 months200-600 mg/dL
4-6 months160-590 mg/dL
7-11 months160-800 mg/dL
1 year280-1040 mg/dL
2 years330-1120 mg/dL
3-5 years390-1360 mg/dL
6-8 years440-1470 mg/dL
9-11 years480-1530 mg/dL
12-16 years500-1590 mg/dL
17-60 years600-1640 mg/dL
≥61 years600-1540 mg/dL
$24
IMMUNOGLOBULINS, IgM
Test Details
Increased IgM is associated with Waldenström's macroglobulinemia, infectious mononucleosis, viral infections, nephrotic syndrome, and estrogen therapy; decreased IgM is found in selective IgM deficiency, Bruton's Disease, and acquired immune deficiency.

Reference Range(s)

IgM, Serum
Cord Blood6-25 mg/dL
1-28 days10-50 mg/dL
1-3 months10-72 mg/dL
4-6 months12-86 mg/dL
7-11 months13-120 mg/dL
1 year23-130 mg/dL
2 years25-135 mg/dL
3-5 years26-150 mg/dL
6-8 years25-150 mg/dL
9-11 years40-160 mg/dL
12-16 years41-170 mg/dL
≥17 years50-300 mg/dL
$24
IMMUNOGLOBULINS, IgE
Test Details
For diagnosis of allergic disease. A normal IgE level does not exclude the possible presence of an allergic disorder.

Reference Range(s)

IgE, Serum
≤6 Weeks≤9kU/L
3 Months≤17kU/L
6 Months≤30kU/L
9 Months≤39kU/L
12 Months≤53kU/L
2 Years≤93kU/L
3 Years≤128kU/L
4 Years≤160kU/L
5 Years≤192kU/L
6 Years≤224kU/L
7 Years≤248kU/L
8 Years≤280kU/L
9 Years≤304kU/L
10 Years≤328kU/L
Adult≤114kU/L
$24
Insulin
Test Details

For diagnosis and monitoring of diabetes and insulin-secreting tumors.

Reference Range(s):

≤19.6 uIU/mL

RiskuIU/mL
Optimal≤19.6
ModerateN/A
High>19.6
$28
Iodine
Test Details

Iodine is an essential element that is required for thyroid hormone production. The measurement of iodine serves as an index of adequate dietary intake and iodine overload, particularly from iodine-containing drugs such as Amiodarone.

Reference Range(s):

52-109 mcg/L

$63
Iron, Total and TIBC
Test Details

Serum iron quantification is useful in confirming the diagnosis of iron-deficiency anemia or hemochromatosis. The measurement of total iron binding in the same specimen may facilitate the clinician's ability to distinguish between low serum iron levels caused by iron deficiency from those related to inflammatory neoplastic disorders. The assay for iron measures the amount of iron which is bound to transferrin. The total iron binding capacity (TIBC) measures the amount of iron that would appear in blood if all the transferrin were saturated with iron. It is an indirect measurement of transferrin concentrations but expressed as an iron measurement. To obtain the percent saturation, the serum iron is divided by the TIBC which gives the actual amount of saturated transferrin. The percent saturation is low in iron deficiency and high in iron storage diseases.

Reference Range(s):

Iron, Total

Age		Male
(mcg/dL)		Female
(mcg/dL)
<1 Month32-11229-127
1-11 Months27-10925-126
1-3 Years29-9125-101
4-19 Years27-16427-164
20-29 Years50-19540-190
30-49 Years50-18040-190
≥50 Years50-18045-160

Iron Binding Capacity

Age		Male
mcg/dL (calc)		Female
mcg/dL (calc)
<1 Month94-23294-236
1-5 Months116-32289-311
6-11 Months176-384138-365
1-19 Years271-448271-448
≥20 Years250-425250-450

% Saturation

Age		Male
% (calc)		Female
% (calc)
<1 Year10-4812-45
1-12 Years12-4813-45
13-19 Years16-4815-45
≥20 Years20-4816-45
$22
Lactate Dehydrogenase (LD)
Test Details

Elevations in serum lactate dehydrogenase occur from myocardial infarction, liver disease, pernicious and megaloblastic anemia, pulmonary emboli, malignancies, and muscular dystrophy. Since lactic dehydrogenase is present in many body tissues, it's diagnosis usefulness is limited. Tissue specificity may be enhanced by isoenzyme analysis.

Reference Range(s):

 Male (U/L)Female (U/L)
<1 Month125-735145-765
1-11 Months170-450190-420
1-3 Years155-345165-395
4-6 Years155-345135-345
7-10 Years140-270140-270
11-13 Years

110-250

110-250
14-17 Years110-230110-230
18-49 Years100-220100-200
>49 Years120-250120-250
$19
Lactate Dehydrogenase Isoenzymes
Test Details

LDH Total should be done before performing this test. If we are not the ones that drew your LDH, Total, please bring a copy of your results to be included with this lab test

Lactate dehydrogenase (LD) is present in many different organs and tissues such as liver, heart, muscles, kidney, lungs and blood. The usual designation of isoenzymes is LD-I, LDII, LD-III, LD-IV and LD-V. LD isoenzymes tissue specificity is derived from the fact that LD subunits are synthesized in well-defined ratios and could be used in investigating unexplained causes of Total LD elevations and detection of macro-LD. Do not use LD isoenzymes to detect myocardial injury.

Reference Range(s):

LD 119-38 %
LD 230-43 %
LD 316-26 %
LD 43-12 %
LD 53-14 %
$53
Lead
Test Details

Blood lead level analysis is performed to evaluate the body burden of lead.

Reference Range(s):

Birth-6 years<5 mcg/dL
>6 years<5 mcg/dL
$21
Leptin
Test Details

Leptin is an adipocyte-derived hormone that is essential for normal body weight regulation. Leptin production is under neuroendocrine control so that serum concentrations vary directly with the amount of triglycerides stored in adipose tissue depots.

Reference Range(s)

Pediatric male and female
5-9.9 Years0.6-16.8 ng/mL
10-13.9 Years1.4-16.5 ng/mL
14-17.9 Years0.6-24.9 ng/mL

Adult Lean Subjects (18-71 Years) with BMI range of 18-25
Male0.3-13.4 ng/mL
Female4.7-23.7 ng/mL

Adult Subjects (19-60 Years) with BMI range of 25-30
Male1.8-19.9 ng/mL
Female8.0-38.9 ng/mL
$53
LH
Test Details

This test is useful in the differential diagnosis of pituitary and gonadal insufficiency and in children with precocious puberty.

Reference Range(s)

Male
18-59 Years1.5-9.3 mIU/mL
≥60 Years1.6-15.2 mIU/mL
Female
Follicular Phase1.9-12.5 mIU/mL
Mid-Cycle Peak8.7-76.3 mIU/mL
Luteal Phase0.5-16.9 mIU/mL
Postmenopausal

10.0-54.7 mIU/mL

Children (<18 years old): LH reference ranges established on post-pubertal patient population. Reference range not established for pre-pubertal patients using this assay. For pre-pubertal patients, the Quest Diagnostics LH, Pediatrics assay is recommended (test code 36086).
$21
Lipase
Test Details

Confirmatory evidence for diagnosis of pancreatitis.

Reference Range(s)

7-60 U/L

$22
LIPID PNL W/REF DIR LDL
Test Details

The Lipid Panel with Reflex to Direct LDL panel includes evaluation of total cholesterol, HDL-cholesterol, triglyceride (TG), LDL-cholesterol (calculated), cholesterol/HDL ratio (calculated), and non-HDL cholesterol; direct LDL-C measurement will be performed at additional cost if the TG level is >400 mg/dL. This panel is useful in the detection, classification, and monitoring of hyperlipidemia, especially those expected to have highly elevated TG levels.

Reference Range(s)

Total CholesterolMale
(mg/dL)		Female
(mg/dL)
<20 Years<170<170
≥20 Years<200<200
HDL Cholesterol  
<20 Years>45>45
≥20 Years≥40≥50
Triglycerides  
≤9 Years<75<75
10-19 Years<90<90
≥20 Years<150<150
LDL-Cholesterol (Calc)  
<20 Years<110<110
≥20 Years<100<100
Cholesterol/HDL Ratio (Calc)<5.0<5.0
Non-HDL Cholesterol  
<20 Years<120<120
≥20 Years<130<130

 

$26
LYME AB w/Reflex Immunoblot
Test Details

Lyme disease is caused by a bacterium borrelia burgdorferi and is transmitted by ticks. A screening test with high sensitivity is used as the first step in the CDC recommended algorithm. Immunoblot testing qualitatively examines, with high specificity, antibodies in a patient's specimen. Immunoblot testing is appropriate for confirming a detected screening result.

Reference Range(s)

IndexInterpretation
<0.90Negative
0.90-1.09Equivocal
>1.09Positive
As recommended by the Food and Drug Administration (FDA), all samples with positive or equivocal results in a Borrelia burgdorferi antibody screen will be tested using a blot method. Positive or equivocal screening test results should not be interpreted as truly positive until verified as such using a supplemental assay (e.g., B. burgdorferi blot).
The screening test and/or blot for B. burgdorferi antibodies may be falsely negative in early stages of Lyme disease, including the period when erythema migrans is apparent.
$73
Macroprolactin
Test Details
For some patients the level of Prolactin measured by immunoassay may be inaccurate with respect to the level of monomeric, biologically active Prolactin. The Macroprolactin by PEG Precipitation test can help to identify if a patient sample has elevated Prolactin due to mostly inactive protein-bound Prolactin (Macroprolactin).
Reference Range(s)

Prolactin, Total
Females (>18 years)
  Non-pregnant3.0-30.0 ng/mL
  Pregnant10.0-209.0 ng/mL
  Post-menopausal2.0-20.0 ng/mL

Males (>18 years)2.0-18.0 ng/mL
Stages of Puberty (Tanner Stages)
 FemaleObservedMaleObserved
Stage I3.6-12.0 ng/mL≤10.0 ng/mL
Stage II-III2.6-18.0 ng/mL≤6.1 ng/mL
Stage IV-V3.2-20.0 ng/mL2.8-11.0 ng/mL
Prolactin, Monomeric
Adult Reference Ranges for Prolactin, Monomeric
Females3.2-25.2 ng/mL
Males3.4-14.8 ng/mL
$249
Magnesium
Test Details
Magnesium measurements are used in the diagnosis and treatment of hypomagnesemia (abnormally low plasma levels of magnesium) and hypermagnesemia (abnormally high plasma levels of magnesium). Magnesium is decreased in chronic nephritis, acute pancreatitis, and alcoholic cirrhosis. It is increased in acute or chronic renal failure and Addison's Disease.

Reference Range(s)

1.5-2.5 mg/dL
$19
Manganese
Test Details
Manganese deficiency produces growth disorders, alters skeletal and cartilage formation and impairs reproduction. Industrial workers absorb manganese mainly through the lungs.
Reference Range(s)
4.2-16.5 mcg/L
$34
Mercury
Test Details
Mercury, a highly toxic metal, is present in select industrial environments and in contaminated ocean fish.

Reference Range(s)

≤10 mcg/L
$26
Methylmalonic Acid (MMA)
Test Details
The Methylmalonic Acid (MMA) test is used in the diagnosis of acquired cobalamin (vitamin B12) deficiency in adults and to screen for inherited organic acidemia in neonates and infants. Elevated MMA in either blood or urine indicates vitamin B12 deficiency in adults, with MMA acting as a functional biomarker for vitamin B12 status. In neonates and infants, elevated MMA is associated with inborn errors of metabolism.
Reference Range(s)

87-318 nmol/L
$41
Molybdenum
Test Details
Molybdenum is an essential trace element. In anemia, molybdenum concentration decreases in both erythrocytes and plasma. Toxic doses can cause anemia and abnormal copper metabolism.
Reference Range(s)
<2.2 mcg/L
$34
Mononucleosis, Heterophile
Test Details
Heterophile antibodies, in patients with infectious mononucleosis, may be present as early as the fourth day of illness, and by the twenty-first day of illness, 90% of patients will exhibit a positive test. The Epstein-Barr virus causes infectious mononucleosis.
Reference Range(s)

Negative
$28
MTHFR, DNA mutation
Test Details
Reduced methylenetetrahydrofolate reductase (MTHFR) enzyme activity is a genetic risk factor for hyperhomocysteinemia, especially when present with low serum folate levels. Two common variants in the MTHFR gene result in reduced enzyme activity. The "thermolabile" variant C677T [NM 005957.3: c.665C>T (p.A222V)] and A1298C [c. 1286A>C (p.E429A)] occur frequently in the general population. Mild to moderate hyperhomocysteinemia has been identified as a risk factor for coronary artery disease and venous thromboembolism. Hyperhomocysteinemia is multifactorial, involving a combination of genetic, physiologic and environmental factors. Recent studies do not support the previously described association of increased risk for coronary artery disease and venous thromboembolism with mild hyperhomocysteinemia caused by reduced MTHFR activity.
$192
N-Telopeptide
Test Details
Serum N-Telopeptide (NTx) levels may be used in predicting skeletal response (bone mineral density) to antiresorptive therapy and in monitoring bone resorption changes following initiation of antiresorptive therapy. Prior to initiating antiresorptive therapy, a serum NTx level is used to determine the probability for a decrease in bone mineral density (BMD) after one year in postmenopausal women treated with hormonal antiresorptive therapy relative to those treated with calcium supplementation.

Reference Range(s)

0-18 YearsNot established
Male ≥19 Years5.4-24.2 nM BCE
Female ≥19 Years6.2-19.0 nM BCE
$157
Phosphate (as Phosphorus)
Test Details

Serum phosphorus (Phosphate) levels alone are of limited diagnostic value and should be correlated with serum calcium levels. An increased phosphorus with decreased calcium suggests either hypoparathyroidism or renal disease. A decreased phosphorus and an increased calcium suggests hyperparathyroidism or sarcoidosis. When both calcium and phosphorus are decreased diagnostic considerations include malabsorption, vitamin D deficiency and renal tubular acidosis. Increased phosphorus and normal or increased calcium suggests Milk-alkali syndrome or hypervitaminosis D.

Reference Range(s)

<1 Week4.0-9.0 mg/dL
1 Week-2 Years4.0-8.0 mg/dL
3-12 Years3.0-6.0 mg/dL
13-64 Years2.5-4.5 mg/dL
>64 Years2.1-4.3 mg/dL
$18
Potassium
Test Details
Potassium measurements are useful in monitoring electrolyte balance in the diagnosis and treatment of disease conditions characterized by low or high blood potassium levels. Potassium is elevated in adrenal cortical insufficiency, acute renal failure and in some cases of diabetic acidosis. Potassium is decreased in diuretic administration and renal tubular acidosis.

Reference Range(s)
≤1 Week3.2-5.5 mmol/L
8-27 Days3.4-6.0 mmol/L
1-5 Months3.5-5.6 mmol/L
6 Months-1 Year3.5-6.1 mmol/L
2-19 Years3.8-5.1 mmol/L
≥20 years3.5-5.3 mmol/L
$18
Progesterone
Test Details

Levels increase sharply during the luteal phase of the menstrual cycle. The level increases from 9 to 32 weeks of pregnancy.

Reference Range(s)

Male<1.4 ng/mL
Female
Follicular Phase<1.0 ng/mL
Luteal Phase2.6-21.5 ng/mL
Postmenopausal<0.5 ng/mL
Pregnancy
First Trimester4.1-34.0 ng/mL
Second Trimester24.0-76.0 ng/mL
Third Trimester52.0-302.0 ng/mL
Children (<18 years old): Progesterone reference ranges established on post-pubertal patient population. Reference range not established for pre-pubertal patients using this assay. For pre-pubertal patients, the Nichols progesterone, LC/MS/MS assay is recommended (test code 17183).
$23
Prolactin
Test Details
During pregnancy and postpartum lactation, serum prolactin can increase 10- to 20-fold. Exercise, stress, and sleep also cause transient increases in prolactin levels. Consistently elevated serum prolactin levels (>30 ng/mL), in the absence of pregnancy and postpartum lactation, are indicative of hyperprolactinemia. Hypersecretion of prolactin can be caused by pituitary adenomas, hypothalamic disease, breast or chest wall stimulation, renal failure or hypothyroidism. A number of drugs, including many antidepressants, are also common causes of abnormally elevated prolactin levels. Hyperprolactinemia often results in galactorrhea, amenorrhea, and infertility in females, and in impotence and hypogonadism in males. Renal failure, hypothyroidism, and prolactin-secreting pituitary adenomas are also common causes of abnormally elevated prolactin levels.

Reference Range(s)

Adult Males2.0-18.0 ng/mL
Adult Females
  Non-Pregnant3.0-30.0 ng/mL
  Pregnant10.0-209.0 ng/mL
  Postmenopausal2.0-20.0 ng/mL
Stages of Puberty (Tanner Stages)
Female ObservedMale Observed
Stage I3.6.12.0 ng/mL≤10.0 ng/mL
Stage II-III2.6-18.0 ng/mL≤6.1 ng/mL
Stage IV-V3.2-20.0 ng/mL2.8-11.0 ng/mL
$27
Prothrombin Time with INR
Test Details

Screening test for abnormalities of coagulation factors that are involved in the extrinsic pathway. Also used to monitor effects of Warfarin therapy and to study patients with hereditary and acquired clotting disorders.

Reference Range(s)

INR
≤3 monthsNot established
>3 months
Reference range0.9-1.1
Moderate-intensity Warfarin therapy2.0-3.0
Higher-intensity Warfarin therapy3.0-4.0

PT
≤3 monthsNot established
>3 months9.0-11.5 sec
$20
PSA, total
Test Details

Elevated serum PSA concentrations have been reported in men with prostate cancer, benign prostatic hypertrophy, and inflammatory conditions of the prostate.

Reference Range(s)

Male≤4.0 ng/mL
FemaleNot established
$25
PSA, Total and Free
Test Details
In men over 50 years with total PSA between 4.0 and 10.0 ng/mL, the percent (%) free PSA gives an estimate of the probability of cancer. In these circumstances the measurement of the % free PSA may aid in avoiding unnecessary biopsies.

Elevated levels of Prostate Specific Antigen (PSA) have been associated with benign and malignant prostatic disorders. Studies indicate that in men 50 years or older measurement of PSA is a useful addition to the digital rectal exam in the early detection of prostate cancer. In addition, PSA decreases to undetectable levels following complete resection of the tumor and may rise again with recurrent disease or persist with residual disease. Thus, PSA levels may be of assistance in the management of prostate cancer patients.
Reference Range(s)
PSA, Total
Male≤4.0 ng/mL
FemaleNot established
PSA, FreeSee Laboratory Report
PSA, % Free
Male>25 % (calc)
FemaleNot established
$56
PTH w/Calcium
Test Details
The assay is useful in making the diagnosis of primary hyperparathyroidism, secondary hyperparathyroidism, and a differential diagnosis of hypercalcemia. The assay helps in distinguishing hypercalcemia cause by either primary hyperparathyroidism or malignant disease.
Reference Range(s)
Calcium
strong>AgeMale (mg/dL)Female (mg/dL)
<1 Month8.4-10.68.4-10.6
1-11 Months8.7-10.58.7-10.5
1-3 Years8.5-10.68.5-10.6
4-19 Years8.9-10.48.9-10.4
20-49 Years8.6-10.38.6-10.2
>49 Years8.6-10.38.6-10.4
Parathyroid Hormone, Intact
<1 Year 8-70 pg/mL
1-7 Years14-66 pg/mL
8-18 Years14-85 pg/mL
≥19 Years16-77 pg/mL
Interpretive Guide
Intact PTHCalcium
Normal ParathyroidNormalNormal
HypoparathyroidismLow or Low NormalLow
Hyperparathyroidism
  PrimaryNormal or HighHigh
  SecondaryHighNormal or Low
  TertiaryHighHigh
Non-Parathyroid
 HypercalcemiaLow or Low NormalHigh
$79
PTH w/Ionized Ca
Test Details
The assay is useful in making the diagnosis of primary hyperparathyroidism, secondary hyperparathyroidism, and a differential diagnosis of hypercalcemia. The assay helps in distinguishing hypercalcemia caused by either primary hyperparathyroidism or malignant disease.

Includes(s)


PTH, Intact
Calcium
Calcium, Ionized

$86
PTH w/out Calcium
Test Details
This test measures intact parathyroid hormone (PTH) levels in blood and may aid in the differential diagnosis of hypocalcemia and hypercalcemia. This test may also be useful in the diagnosis and management of disorders such as hyperparathyroidism, hypoparathyroidism, hypercalcemia of malignancy, or mineral and bone disorder (MBD) due to chronic kidney disease (CKD) [1-4].

PTH measurement is useful for initial evaluation of hypocalcemia, when low or inappropriately normal PTH levels would suggest a lack of adequate PTH secretion (hypoparathyroidism). For differential diagnosis of hypercalcemia, high or inappropriately normal levels of PTH would suggest over-secretion of PTH (hyperparathyroidism or ectopic PTH production), while low levels point to the possibility of hypercalcemia due to a tumor [1,2]. This test may also be helpful in detecting parathyroid disorders caused by chronic calcium and vitamin D deficiency after bariatric surgery [3]. PTH level is recommended as one of the biomarkers to monitor MBD in patients with CKD, starting at CKD stage G3a
Reference Range(s)
Parathyroid Hormone, Intact
<1 Year 8-70 pg/mL
1-7 Years14-66 pg/mL
8-18 Years14-85 pg/mL
≥19 Years16-77 pg/mL
Interpretive Guide
Intact PTHCalcium
Normal ParathyroidNormalNormal
HypoparathyroidismLow or Low NormalLow
Hyperparathyroidism
  PrimaryNormal or HighHigh
  SecondaryHighNormal or Low
  TertiaryHighHigh
Non-Parathyroid
 HypercalcemiaLow or Low NormalHigh
$75
Renal Function Panel
Test Details

  • Albumin
  • BUN/Creatinine Ratio (calculated)
  • Calcium
  • Carbon Dioxide
  • Chloride
  • Creatinine
  • Estimated Glomerular Filtration Rate (calculated)
  • Glucose
  • Phosphate (as Phosphorus)
  • Potassium
  • Sodium
  • Urea Nitrogen
    		• $19
    Respiratory Allergy Profile Region VIII: IA, IL, MO
    Test Details

    IgE allergy testing for:
    Alternaria alternata (a mold) (m6)
    Aspergillus fumigatus (m3)
    Bermuda grass (Cynodon dactylon) (g2)
    Cat dander (e1)
    Cladosporium herbarum (Hormodendrum) (m2)
    Cockroach (i6)
    Common Ragweed (short) (w1)
    Cottonwood (Populous deltoides) (t14)
    Dermatophagoides  farinae (d2)
    Dermatophagoides pteronyssinus (d1)
    Dog dander (e5)
    Elm (t8)
    Maple (box elder) (t1)
    Maple leaf sycamore, London Plane (t11)
    Mountain cedar (Juniperus sabinoides) (t6)
    Mouse Urine Proteins (e72)
    Mulberry (t70)
    Oak (t7)
    Pecan/Hickory (Carya soecue, pecan) (t22)
    Penicillium notatum (m1)
    Rough marsh elder (Iva) (w16)
    Rough pigweed (Amaranthus retroflexus) (w14)
    Russian thistle (Saltwort, Salsola kali) (w11)
    Timothy grass (Phleum pratense) (g6)
    Walnut (Juglans californica) (t10)
    White ash (Fraxinus americana) (t15)


    If you do not wish to have the entire panel done, you can get results for any specific allergen from the results list below. (Each individual test is $21)
    		$183
    Reticulocyte
    Test Details
    Use in evaluating erythropoietic activity.Reference Range(s)0.5%-1.5%
    		$27
    Reverse T3
    Test Details
    3,3',5'-Triiodothyronine (reverse T3, rT3) is, along with 3,3,5'-Triiodothyronine (T3) a deiodinated metabolite of thyroxine (T4), the major secretory product of the thyroid gland and is secreted into the bloodstream. Unlike T3, however, rT3 is thought to be metabolically inert.
    The process of 5'-monodeiodination that converts T4 to T3, and rT3 to diiodothyronine (DTT) is inhibited in a wide variety of conditions, collectively referred to as nonthyroidal illnesses (NTI) or the 'euthyroid sick' state. These conditions include fasting, malnutrition, poorly controlled diabetes mellitus, trauma, surgery, and systemic illness. Consequently, in patients with NTI the serum T3 level typically decreases, and the rT3 often, but not always, increases.

    Reference Range(s)
    8-25 ng/dL
    		$43
    Rubella Antibody (IgG)
    Test Details

    Rubella is an acute exanthematous viral infection of children and adults. Rash, fever and lymphadenopathy characterize the illness. While many infections are subclinical, this virus has the potential to cause fetal infection with resultant birth defects.
    Diagnosis of a Rubella infection is best made serologically. In the absence of a current or recent infection, a demonstration of specific IgG on a serum sample is evidence of immunity to Rubella.

    IndexInterpretation
    <0.90Not consistent with immunity
    0.90-0.99Equivocal
    ≥1.00Consistent with immunity
    The presence of rubella IgG antibody suggests immunization or past or current infection with rubella virus.
    		$26
    RA Panel
    Test Details
    The combination of RF and anti-CCP antibodies provide greater specificity for the diagnosis of Rheumatoid Arthritis (RA). CCP antibodies may be present earlier than RF and often indicate increased erosive disease in RA.

    Reference Range(s)

    Rheumatoid Factor<14 IU/mL
    CCP Antibody, IgG
      Negative<20
      Weak Positive20-39
      Moderate/Strong Positive40-59
      Strong Positive>59
    		$64
    Rheumatoid Factor
    Test Details
    Elevated RF is found in collagen vascular diseases such as SLE, rheumatoid arthritis, scleroderma, Sjogren's syndrome, and in other conditions such as leprosy, tuberculosis, syphilis, malignancy, thyroid disease and in a significant percentage of otherwise normal elderly patients.

    Reference Range(s)

    <14 IU/mL
    		$24
    RNP Antibody
    Test Details
    RNP Antibodies have been associated with Mixed Connective Tissue disease.

    Reference Range(s)

    <1.0  Negative IA
    		$59
    SBHG
    Test Details

    Testosterone, dihydrotestosterone and estrogens circulate in serum bound to Sex Hormone Binding Globulin (SHBG). SHBG concentrations are increased in pregnancy, hyperthyroidism, cirrhosis, oral estrogen administration and by certain drugs. Concentrations are decreased by testosterone, hypothyroidism, Cushings syndrome, acromegaly and obesity.

    <3 YearsNot established 
      Male Female
    3-9 Years 32-158 nmol/L32-158 nmol/L
    10-13 Years20-166 nmol/L24-120 nmol/L
    14-17 Years20-87 nmol/L12-150 nmol/L
    18-55 Years10-50 nmol/L17-124 nmol/L
    >55 Years22-77 nmol/L14-73 nmol/L
    		$28
    Sed Rate (ESR)
    Test Details

    Useful in differentiating inflammatory and neoplastic diseases and as an index of disease severity. CRP is also useful in monitoring inflammatory disease states.

     MaleFemale
    ≤50 Years≤15 mm/h≤20 mm/h
    >50 Years≤20 mm/h≤30 mm/h
    		$22
    Selenium
    Test Details
    Selenium (Se) is a key component of a number of functional selenoproteins required for normal health. The best known of these are the antioxidant glutathione peroxidase enzymes, which remove hydrogen and damaging lipid and phospholipid hydroperoxides generated in vivo by free radicals and other oxygen-derived species. If not removed, lipid hydroperoxides impair membrane structure and function and cause blood-clotting disturbances by decreasing the production of prostacyclin while increasing the production of thromboxane.

    Reference Range(s)

    <20 yearsNot Established
    20-50 years115-240 mcg/L
    >50 years100-250 mcg/L
    		$34
    Sjogrens AB
    Test Details
    Sjögren's Antibody (SS-B) is detected in approximately 15% of patients with Sjögren's Syndrome. Sjögren's Antibody (SS-B) is present only if Sjögren's Antibody (SS-A) is also detected. The presence of both antibodies (SS-A and SS-B) strengthen the diagnosis of Sjögren's Syndrome and conveys prognostic information.

    Reference Range(s)

    <1.0 AINegative
    		$64
    Shingles (IgM)
    Test Details

    Varicella-Zoster Virus (VZV) causes chicken pox and when reactivated, potentially decades later, causes shingles. Twenty percent of adults will develop shingles, a rash or blister of the skin that may cause severe pain.

    VZV Ab (IgM)≤0.90
    Interpretive criteria
    0.00-0.90Negative
    0.91-1.09Equivocal
    ≥1.10Positive
    		$29
    Tacrolimus
    Test Details
    Tacrolimus is an immunosuppressant drug which has been shown to be effective for the treatment of rejection following transplantation.

    You should try and have specimen collected within 1 hour of your next dose.

    No definitive therapeutic or toxic ranges have been established. Optimal blood drug levels are influenced by type of transplant, patient response, time post-transplant, co-administration of other drugs, and drug formulation.

    The following trough range is a suggested guideline: 5.0-20.0 mcg/L

    		$77
    TBG
    Test Details

    Thyroxine-binding globulin (TBG), a glycoprotein produced in the liver, binds both thyroxine (T4) and triiodothyronine (T3) with high affinity. Because TBG accounts for 76% of plasma protein thyroxine-binding activity, an increase or decrease in its circulating level alters total concentrations of T4 and T3 in blood, leading to potential confusion with true thyroid gland dysfunction. A number of diseases and medications, as well as inherited alterations in TBG gene expression, can change the serum TBG concentration. Measurement of TBG is useful in distinguishing quantitative TBG derangements from thyroid dysfunction. This analyte is elevated with estrogen therapy (especially oral contraceptive agents), during pregnancy and or hepatitis. Serum TBG may be decreased in cirrhosis, in the nephritic syndrome and by androgens.

    Adult Male12.7-25.1mcg/mL
    Adult Female13.5-30.9mcg/mL
    Pediatric  
      4-6 Years14.8-32.9mcg/mL
      7-8 Years16.3-30.7mcg/mL
      9-10 Years15.8-27.4mcg/mL
      11 Years15.5-27.4mcg/mL
      12 Years14.8-26.2mcg/mL
      13 Years13.8-25.2mcg/mL
      14 Years12.2-25.2mcg/mL
      15 Years10.8-23.8mcg/mL
      16 Years10.0-23.8mcg/mL
      17 Years8.5-23.1mcg/mL
    		$84
    Testosterone Panel
    Test Details

    Helpful in assessing testicular function in males and managing hirsutism, virilization in females.

    • Testosterone, Total, MS
    • Testosterone, Free
    • Testosterone, Bioavailable
    • Sex Hormone Binding Globulin (SHBG)
    • Albumin
    		$44
    TESTOSTERONE, Free, total, SBHG
    Test Details

    Testosterone, Total, Males (Adult), Immunoassay: Due to changes in testosterone levels throughout the day, two morning (8:00-10:00 a.m.) specimens obtained on different days are recommended by The Endocrine Society for screening.

    Reference Range(s)

    Testosterone, Total, Males (Adult), Immunoassay

    Male250-827 ng/dL
    FemaleNot applicable

    All test requests for Testosterone on female and pediatric (<18 years) patients must use test code 15983 - Testosterone, Total, MS.

    Albumin3.6-5.1 g/dL


    Sex Hormone Binding Globulin

    AgeMale (nmol/L)Female (nmol/L)
    <3 YearsNot establishedNot established
    3-9 Years32-15832-158
    10-13 Years20-16624-120
    14-17 Years20-8712-150
    18-55 Years10-5017-124
    >55 Years22-7714-73


    Free Testosterone

    AgeMale (pg/mL)Female
    18-69 Years46.0-224.0Not applicable
    >69 Years6.0-73.0Not applicable

    Bioavailable Testosterone

    AgeMale (ng/dL)Female
    18-69 Years110.0-575.0Not applicable
    >69 Years15.0-150.0Not applicable
    		$39
    THYROID PANEL W/TSH
    Test Details

    Thyroid Panel Includes: T3 Free, T3 Uptake, T4 (Thyroxine) Total, Free T4 Index (T7), TSH

    Reference Range(s)

    T3 Free:

    <1 MonthNot established
    1-23 Months3.3-5.2 pg/mL
    2-12 Years3.3-4.8 pg/mL
    13-20 Years3.0-4.7 pg/mL
    >20 Years    2.3-4.2 pg/mL

    T3 Uptake:    22-35.5%,

    Decreased: Pregnancy, estrogens, hyperproteinemia, acute intermittent porphyria.
    Increased: Androgens, hyperproteinemia, stress, acute liver disease.

    T4 (Thyroxine) Total:  

    For diagnosis of hypothyroidism and hyperthyroidism.

    Male (mcg/dL)Female (mcg/dL)
    <1 Month4.5-17.24.5-17.2
    1-23 Months5.9-13.95.9-13.9
    2-12 Years5.7-11.65.7-11.6
    13-20 Years5.1-10.35.3-11.7
    >20 Years4.9-10.55.1-11.9

     

    Free T4 Index (T7)1.4-3.8

    TSH

    For differential diagnosis of primary, secondary, and tertiary hypothyroidism. Also useful in screening for hyperthyroidism. This assay allows adjustment of exogenous thyroxine dosage in hypothyroid patients and in patients on suppressive thyroxine therapy for thyroid neoplasia.

    Premature Infants (28-36 Weeks) 
      1st Week of Life0.20-27.90 mIU/L
    Term Infants (>37 Weeks) 
      Serum or Cord Blood1.00-39.00 mIU/L
      1-2 Days3.20-34.60 mIU/L
      3-4 Days0.70-15.40 mIU/L
      5 Days-4 Weeks1.70-9.10 mIU/L
      1-11 Months0.80-8.20 mIU/L
      1-19 Years0.50-4.30 mIU/L
      ≥20 Years0.40-4.50 mIU/L
    Pregnancy 
      First Trimester0.26-2.66 mIU/L
      Second Trimester0.55-2.73 mIU/L
      Third Trimester0.43-2.91 mIU/L
    		$44
    Thyroid Peroxidase and Thyroglobulin Antibodies
    Test Details
    Measurement of thyroglobulin antibodies and thyroid peroxidase antibodies is useful in the diagnosis and management of a variety of thyroid disorders including autoimmune thyroiditis, Hashimoto's Disease, Graves Disease and certain types of goiter.

    Reference Range(s)


    Thyroid Peroxidase Ab  <9 IU/mL
    Thyroglobulin Ab             ≤1 IU/mL
    		$43
    TICK BORNE DISEASE, ANTIBODY PANEL
    Test Details

    There is substantial clinical overlap among tick-borne diseases caused by Anaplasma, Babesia, Borrelia, and Ehrlichia. Some infections can progress to severe complications such as anemia, hepatitis and pneumonia.. More than one infectious agent may be transmitted by the same tick, and rates of co-infection are not well defined since clinicians may only suspect a single tick-borne disease etiology.

    - Anaplasma phagocytophilum Antibodies (IgG, IgM)
    - WA1 IgG Antibody, IFA
    - Babesia microti Antibodies (IgG, IgM), IFA
    - Lyme Disease Ab with Reflex to Blot (IgG, IgM)
    - Ehrlichia chaffeensis (IgG, IgM)

    Reference Range(s)

    Anaplasma phagocytophilum Antibodies (IgG, IgM)

    Anaplasma phagocytophilum is a tick-borne agent that causes an acute febrile illness that often resembles Rocky Mountain spotted fever.

    A. phagocytophilum IgG<1:64
    A. phagocytophilum IgM<1:20

    WA1 IgG Antibody, IFA:  < 1:256

    Babesia duncani, also known as WA1, causes symptoms similar to those seen in cases of babesiosis caused by Babesia microti. Most of the documented cases have occurred in the Pacific Northwest.

    Babesia microti Antibodies (IgG, IgM), IFA

    Babesia serological testing is used to diagnose infection by the Babesia tick-borne protozoan. Infection may cause hemolytic anemia.

    Babesia microti Antibodies IgG  <1:64
    Babesia microti Antibodies IgM  <1:20

    Lyme Disease Ab with Reflex to Blot (IgG, IgM)

    Lyme disease is caused by a bacterium borrelia burgdorferi and is transmitted by ticks. A screening test with high sensitivity is used as the first step in the CDC recommended algorithm. Immunoblot testing qualitatively examines, with high specificity, antibodies in a patient's specimen. Immunoblot testing is appropriate for confirming a detected screening result.

    IndexInterpretation
    <0.90Negative
    0.90-1.09Equivocal
    >1.09Positive

    Ehrlichia chaffeensis (IgG, IgM)

    Human Monocytic Ehrlichiosis (HME) is a tick-borne infection caused by Ehrlichia chaffeensis. Infections range in severity from asymptomatic to life-threatening, especially in patients who are immunocompromised.

    E. chaffeensis IgG<1:64
    E. chaffeensis IgM<1:20
    		$264
    Transferrin
    Test Details
    Transferrin is a direct measure of the iron binding capacity. Transferrin is thus useful in assessing iron balance. Iron deficiency and overload are often evaluated with complementary laboratory tests.


    188-341 mg/dL
    		$26
    TSH
    Test Details

    For differential diagnosis of primary, secondary, and tertiary hypothyroidism. Also useful in screening for hyperthyroidism. This assay allows adjustment of exogenous thyroxine dosage in hypothyroid patients and in patients on suppressive thyroxine therapy for thyroid neoplasia.

    Premature Infants (28-36 Weeks) 
      1st Week of Life0.20-27.90 mIU/L
    Term Infants (>37 Weeks) 
      Serum or Cord Blood1.00-39.00 mIU/L
      1-2 Days3.20-34.60 mIU/L
      3-4 Days0.70-15.40 mIU/L
      5 Days-4 Weeks1.70-9.10 mIU/L
      1-11 Months0.80-8.20 mIU/L
      1-19 Years0.50-4.30 mIU/L
      ≥20 Years0.40-4.50 mIU/L
    Pregnancy 
      First Trimester0.26-2.66 mIU/L
      Second Trimester0.55-2.73 mIU/L
      Third Trimester0.43-2.91 mIU/L
    		$21
    Uric Acid
    Test Details

    Serum uric acid measurements are useful in the diagnosis and treatment of numerous renal and metabolic disorders, including renal failure, gout, leukemia, psoriasis, starvation or other wasting conditions, and in patients receiving cytotoxic drugs.

     Male
    (mg/dL)    		Female
    (mg/dL)
    <1 Month

    1.5-3.9

    		1.5-4.6
    1-11 Months1.5-5.61.5-5.4
    1-3 Years2.1-5.61.8-5.0
    4-6 Years1.8-5.52.0-5.1
    7-9 Years1.8-5.41.8-5.5
    10-12 Years2.2-5.82.5-5.9
    13-15 Years3.1-7.02.2-6.4
    16-18 Years2.1-7.62.4-6.6
    ≥19 Years4.0-8.02.5-7.0
    		$18
    VIT B12/FOLATE
    Test Details

    Folic acid deficiency is common in pregnant women, alcoholics, patients with diets that do not include raw fruits and vegetables, and people with structural damage to the small intestine. The most reliable and direct method of diagnosing folate deficiency is the determination of folate levels in both erythrocytes and serum. Low folic acid levels, however, can also be the result of a primary Vitamin B12 deficiency that decreases the ability of cells to take up folic acid.
    B12 is decreased in pernicious anemia, total or partial gastrectomy, malabsorption and certain congenital biochemical disorders.

    Reference Range(s)

    Folate

    ≤4 yearsNot established
    5-9 years>7.1 ng/mL
    10-17 years>8.0 ng/mL
      
    ≥18 years 
      Low<3.4 ng/mL
      Borderline3.4-5.4 ng/mL
      Normal>5.4 ng/mL

    Vit B-12 (Cobalamin)

    ≤4 YearsNot established
    5-9 Years250-1205 pg/mL
    10-17 Years260-935 pg/mL
    >17 Years200-1100 pg/mL
    		$28
    Vitamin A
    Test Details

    Vitamin A is critical for vision, growth, and many cell functions. High concentrations of Vitamin A are seen with renal failure, but this is not associated with toxicity and excessive ingestion. High concentrations are associated with bone fractures. Low concentrations of Vitamin A are consistent with fat malabsorption and are rarely due to inadequate diet.

    1-6 Years20-43 mcg/dL
    7-12 Years26-49 mcg/dL
    13-19 Years26-72 mcg/dL
    Adult38-98 mcg/dL
    		$38
    Vitamin E
    Test Details

    Deficiency of vitamin E may cause extensive neuropathy in young children and, in addition, is suspect as a possible cause of motor and sensory neuropathy in older children and in adults. One likely cause of vitamin E deficiency is intestinal malabsorption, resulting from bowel disease, pancreatic disease, or chronic cholestasis. Other causes of malabsorption of vitamin E include celiac disease, cystic fibrosis, and intestinal lymphangiectasia.

    0-17 Years3.8-18.4 mg/L
    18+ Years5.5-17.0 mg/L
    		$36
    Vitamin B-12
    Test Details

    B12 is decreased in pernicious anemia, total or partial gastrectomy, malabsorption and certain congenital and biochemical disorders.

    ≤4 YearsNot established
    5-9 Years250-1205 pg/mL
    10-17 Years260-935 pg/mL
    >17 Years200-1100 pg/mL
    		$21
    Vitamin D, 25-Hydroxy
    Test Details
    Measurement of serum 25-OH vitamin D concentrations provide a good index of circulating vitamin D activity in patients not suffering from renal disease. Lower than normal 25-OH vitamin D levels can result from a dietary deficiency, poor absorption of the vitamin or impaired metabolism of the sterol in the liver. A 25-OH vitamin D deficiency can lead to bone diseases such as rickets and osteomalacia. Above normal levels can lead to hypercalcemia.  Fasting preferred but not required

    30-100 ng/mL
    		$36
    Vitamin D,1,25-Dihydroxy
    Test Details
    This test measures the bioactive form of vitamin D. It is used in the differential diagnosis of hypocalcemia and to monitor patients with renal osteodystrophy or chronic renal failure. This test is not suitable for diagnosis of vitamin D deficiency and monitoring supplementation in most patients. The 25-hydroxyvitamin D test is the recommended test for those purposes.

    Reference Range(s)

    Vitamin D, 1,25 (OH)2, Total
    1-9 Years31-87 pg/mL
    10-13 Years30-83 pg/mL
    14-17 Years19-83 pg/mL
    Adult18-72 pg/mL
    Vitamin D3, 1,25 (OH)2Not available
    Vitamin D2, 1,25 (OH)2Not available
    Reference ranges are established for total 1,25-dihydroxy vitamin D. Values for subcomponents D2 (derived from plant or fungal sources) and D3 (derived from human or animal sources) are provided for informational purposes only.
    		$69
    WA 1 IgG Antibody
    Test Details
    Babesia duncani, also known as WA1, causes symptoms similar to those seen in cases of babesiosis caused by Babesia microti. Most of the documented cases have occurred in the Pacific Northwest.

    <1:256
    		$71
    Zinc
    Test Details

    Zinc is an essential element involved in a myriad of enzyme systems including wound healing, immune function, and fetal development. Zinc measurements are used to detect and monitor industrial, dietary, and accidental exposure to zinc. Also, zinc measurements may be used to evaluate health and monitor response to treatment.

    Reference Range(s)

    ≤5 Months26-141 mcg/dL
    6-11 Months29-131 mcg/dL
    12-23 Months31-120 mcg/dL
    2-3 Years29-115 mcg/dL
    4-5 Years48-119 mcg/dL
    6-9 Years48-129 mcg/dL
    10-13 Years25-148 mcg/dL
    14-17 Years46-130 mcg/dL
    Adult60-130 mcg/dL
    		$27
    Common Lab Panels
    Not sure what you need? Been awhile since you've seen a doctor?
    We have created some groupings of the most common tests by category below.
    If the title is in Green, It means you must fast 12 hours before the test. If the title is in Red, it means it is a morning lab you must schedule by 11am.
    DescriptionPanel Cost
    Wellness Panel 1
    Complete Metabolic Panel (CMP)
    Test Details

    • Albumin
    • Albumin/Globulin Ratio (calculated)
    • Alkaline Phosphatase
    • ALT
    • AST
    • BUN/Creatinine Ratio (calculated)
    • Calcium
    • Carbon Dioxide
    • Chloride
    • Creatinine with GFR Estimated
    • Globulin (calculated)
    • Glucose
    • Potassium
    • Sodium
    • Total Bilirubin
    • Total Protein
    • Urea Nitrogen
    Hemoglobin A1c
    Test Details
    To assist with control of blood glucose levels, the American Diabetes Association (ADA) has recommended glycated hemoglobin testing (HbA1c) twice a year for patients with stable glycemia, and quarterly for patients with poor glucose control. Interpretative ranges are based on ADA guidelines.

    Reference Range(s)

    <5.7 % of total hemoglobin
    Complete Blood Count (CBC w/DIFF/PLT)
    Test Details

    A complete blood count is used as a screening test for various disease states to include: anemia, leukemia and inflammatory processes.

    Includes:

    • WBC
    • RBC
    • Hemoglobin
    • Hematocrit
    • MCV
    • MCH
    • MCHC
    • RDW
    • Platelet Count
    • MPV and Differential
    • (Absolute and Percent - Neutrophils, Lymphocytes, Monocytes, Eosinophils, and Basophils)


    If abnormal cells are noted on a manual review of the peripheral blood smear or if the automated differential information meets specific criteria, a full manual differential will be performed.

    Lipid Panel
    Test Details

    The Lipid Panel includes evaluation of total cholesterol, HDL-cholesterol, triglyceride (TG), LDL-cholesterol (calculated), cholesterol/HDL ratio (calculated), and non-HDL cholesterol. This panel is useful in the detection, classification, and monitoring of hyperlipidemia, especially those expected to have highly elevated TG levels.

    Reference Range(s)

    Total CholesterolMale
    (mg/dL)    		Female
    (mg/dL)
    <20 Years<170<170
    ≥20 Years<200<200
    HDL Cholesterol  
    <20 Years>45>45
    ≥20 Years≥40≥50
    Triglycerides  
    ≤9 Years<75<75
    10-19 Years<90<90
    ≥20 Years<150<150
    LDL-Cholesterol (Calc)  
    <20 Years<110<110
    ≥20 Years<100<100
    Cholesterol/HDL Ratio (Calc)<5.0<5.0
    Non-HDL Cholesterol  
    <20 Years<120<120
    ≥20 Years<130<130

     

    		$82
    $49
    Wellness Panel 2
    Complete Metabolic Panel (CMP)
    Test Details

    • Albumin
    • Albumin/Globulin Ratio (calculated)
    • Alkaline Phosphatase
    • ALT
    • AST
    • BUN/Creatinine Ratio (calculated)
    • Calcium
    • Carbon Dioxide
    • Chloride
    • Creatinine with GFR Estimated
    • Globulin (calculated)
    • Glucose
    • Potassium
    • Sodium
    • Total Bilirubin
    • Total Protein
    • Urea Nitrogen
    Hemoglobin A1c
    Test Details
    To assist with control of blood glucose levels, the American Diabetes Association (ADA) has recommended glycated hemoglobin testing (HbA1c) twice a year for patients with stable glycemia, and quarterly for patients with poor glucose control. Interpretative ranges are based on ADA guidelines.

    Reference Range(s)

    <5.7 % of total hemoglobin
    Complete Blood Count (CBC w/DIFF/PLT)
    Test Details

    A complete blood count is used as a screening test for various disease states to include: anemia, leukemia and inflammatory processes.

    Includes:

    • WBC
    • RBC
    • Hemoglobin
    • Hematocrit
    • MCV
    • MCH
    • MCHC
    • RDW
    • Platelet Count
    • MPV and Differential
    • (Absolute and Percent - Neutrophils, Lymphocytes, Monocytes, Eosinophils, and Basophils)


    If abnormal cells are noted on a manual review of the peripheral blood smear or if the automated differential information meets specific criteria, a full manual differential will be performed.

    Lipid Panel
    Test Details

    The Lipid Panel includes evaluation of total cholesterol, HDL-cholesterol, triglyceride (TG), LDL-cholesterol (calculated), cholesterol/HDL ratio (calculated), and non-HDL cholesterol. This panel is useful in the detection, classification, and monitoring of hyperlipidemia, especially those expected to have highly elevated TG levels.

    Reference Range(s)

    Total CholesterolMale
    (mg/dL)    		Female
    (mg/dL)
    <20 Years<170<170
    ≥20 Years<200<200
    HDL Cholesterol  
    <20 Years>45>45
    ≥20 Years≥40≥50
    Triglycerides  
    ≤9 Years<75<75
    10-19 Years<90<90
    ≥20 Years<150<150
    LDL-Cholesterol (Calc)  
    <20 Years<110<110
    ≥20 Years<100<100
    Cholesterol/HDL Ratio (Calc)<5.0<5.0
    Non-HDL Cholesterol  
    <20 Years<120<120
    ≥20 Years<130<130

     

    Magnesium
    Test Details
    Magnesium measurements are used in the diagnosis and treatment of hypomagnesemia (abnormally low plasma levels of magnesium) and hypermagnesemia (abnormally high plasma levels of magnesium). Magnesium is decreased in chronic nephritis, acute pancreatitis, and alcoholic cirrhosis. It is increased in acute or chronic renal failure and Addison's Disease.

    Reference Range(s)

    1.5-2.5 mg/dL
    TSH
    Test Details

    For differential diagnosis of primary, secondary, and tertiary hypothyroidism. Also useful in screening for hyperthyroidism. This assay allows adjustment of exogenous thyroxine dosage in hypothyroid patients and in patients on suppressive thyroxine therapy for thyroid neoplasia.

    Premature Infants (28-36 Weeks) 
      1st Week of Life0.20-27.90 mIU/L
    Term Infants (>37 Weeks) 
      Serum or Cord Blood1.00-39.00 mIU/L
      1-2 Days3.20-34.60 mIU/L
      3-4 Days0.70-15.40 mIU/L
      5 Days-4 Weeks1.70-9.10 mIU/L
      1-11 Months0.80-8.20 mIU/L
      1-19 Years0.50-4.30 mIU/L
      ≥20 Years0.40-4.50 mIU/L
    Pregnancy 
      First Trimester0.26-2.66 mIU/L
      Second Trimester0.55-2.73 mIU/L
      Third Trimester0.43-2.91 mIU/L
    Uric Acid
    Test Details

    Serum uric acid measurements are useful in the diagnosis and treatment of numerous renal and metabolic disorders, including renal failure, gout, leukemia, psoriasis, starvation or other wasting conditions, and in patients receiving cytotoxic drugs.

     Male
    (mg/dL)    		Female
    (mg/dL)
    <1 Month

    1.5-3.9

    		1.5-4.6
    1-11 Months1.5-5.61.5-5.4
    1-3 Years2.1-5.61.8-5.0
    4-6 Years1.8-5.52.0-5.1
    7-9 Years1.8-5.41.8-5.5
    10-12 Years2.2-5.82.5-5.9
    13-15 Years3.1-7.02.2-6.4
    16-18 Years2.1-7.62.4-6.6
    ≥19 Years4.0-8.02.5-7.0
    Iron, Total and TIBC
    Test Details

    Serum iron quantification is useful in confirming the diagnosis of iron-deficiency anemia or hemochromatosis. The measurement of total iron binding in the same specimen may facilitate the clinician's ability to distinguish between low serum iron levels caused by iron deficiency from those related to inflammatory neoplastic disorders. The assay for iron measures the amount of iron which is bound to transferrin. The total iron binding capacity (TIBC) measures the amount of iron that would appear in blood if all the transferrin were saturated with iron. It is an indirect measurement of transferrin concentrations but expressed as an iron measurement. To obtain the percent saturation, the serum iron is divided by the TIBC which gives the actual amount of saturated transferrin. The percent saturation is low in iron deficiency and high in iron storage diseases.

    Reference Range(s):

    Iron, Total

    Age    		Male
    (mcg/dL)    		Female
    (mcg/dL)
    <1 Month32-11229-127
    1-11 Months27-10925-126
    1-3 Years29-9125-101
    4-19 Years27-16427-164
    20-29 Years50-19540-190
    30-49 Years50-18040-190
    ≥50 Years50-18045-160

    Iron Binding Capacity

    Age    		Male
    mcg/dL (calc)    		Female
    mcg/dL (calc)
    <1 Month94-23294-236
    1-5 Months116-32289-311
    6-11 Months176-384138-365
    1-19 Years271-448271-448
    ≥20 Years250-425250-450

    % Saturation

    Age    		Male
    % (calc)    		Female
    % (calc)
    <1 Year10-4812-45
    1-12 Years12-4813-45
    13-19 Years16-4815-45
    ≥20 Years20-4816-45
    Gamma Glutamyl Transferase (GGT)
    Test Details

    Elevated GGT is found in all forms of liver disease. Measurement of GGT is used in the diagnosis and treatment of alcoholic cirrhosis, as well as primary and secondary liver tumors. It is more sensitive than alkaline phosphatase, the transaminases, and leucine aminopeptidase in detecting obstructive jaundice, cholangitis, and cholecystitis. Normal levels of GGT are seen in skeletal diseases; thus, GGT in serum can be used to ascertain whether a disease, suggested by elevated alkaline phosphatase, is skeletal or hepatobiliary.

    Reference Range(s)

    Male (U/L)Female (U/L)
    <6 Months12-12215-132
    6-11 Months ≤39 ≤39
    1-12 Years3-223-22
    13-15 Years8-327-18
    16-19 Years9-316-26
    20-29 Years3-703-40
    30-39 Years3-903-50
    40-54 Years3-95 
    40-49 Years 3-55
    50-59 Years 3-70
    55-59 Years3-85 
    ≥60 Years3-703-65
    		$178
    $99
    Complete Thyroid Panel
    Thyroid Panel w/TSH
    Test Details

    Thyroid Panel: T3 Uptake, T3 Free, T4 (Thyroxine) Total, Free T4 Index (T7)
    TSH

    Reference Range(s)

    T3 Uptake:    22-35.5%,

    Decreased: Pregnancy, estrogens, hyperproteinemia, acute intermittent porphyria.
    Increased: Androgens, hyperproteinemia, stress, acute liver disease.

    T4 (Thyroxine) Total:  

    For diagnosis of hypothyroidism and hyperthyroidism.

    Male (mcg/dL)Female (mcg/dL)
    <1 Month4.5-17.24.5-17.2
    1-23 Months5.9-13.95.9-13.9
    2-12 Years5.7-11.65.7-11.6
    13-20 Years5.1-10.35.3-11.7
    >20 Years4.9-10.55.1-11.9

     

    Free T4 Index (T7)1.4-3.8

    Free T3

    <1 Month Not established
    1-23 Months 3.3-5.2 pg/mL
    2-12 Years 3.3-4.8 pg/mL
    13-20 Years 3.0-4.7 pg/mL
    >20 Years 2.3-4.2 pg/mL

    TSH

    For differential diagnosis of primary, secondary, and tertiary hypothyroidism. Also useful in screening for hyperthyroidism. This assay allows adjustment of exogenous thyroxine dosage in hypothyroid patients and in patients on suppressive thyroxine therapy for thyroid neoplasia.

    Premature Infants (28-36 Weeks) 
      1st Week of Life0.20-27.90 mIU/L
    Term Infants (>37 Weeks) 
      Serum or Cord Blood1.00-39.00 mIU/L
      1-2 Days3.20-34.60 mIU/L
      3-4 Days0.70-15.40 mIU/L
      5 Days-4 Weeks1.70-9.10 mIU/L
      1-11 Months0.80-8.20 mIU/L
      1-19 Years0.50-4.30 mIU/L
      ≥20 Years0.40-4.50 mIU/L
    Pregnancy 
      First Trimester0.26-2.66 mIU/L
      Second Trimester0.55-2.73 mIU/L
      Third Trimester0.43-2.91 mIU/L
    Thyroid Peroxidase and Thyroglobulin AB
    Test Details
    Measurement of thyroglobulin antibodies and thyroid peroxidase antibodies is useful in the diagnosis and management of a variety of thyroid disorders including autoimmune thyroiditis, Hashimoto's Disease, Graves Disease and certain types of goiter.

    Reference Range(s)


    Thyroid Peroxidase Ab  <9 IU/mL
    Thyroglobulin Ab             ≤1 IU/mL
    Reverse T3
    Test Details
    3,3',5'-Triiodothyronine (reverse T3, rT3) is, along with 3,3,5'-Triiodothyronine (T3) a deiodinated metabolite of thyroxine (T4), the major secretory product of the thyroid gland and is secreted into the bloodstream. Unlike T3, however, rT3 is thought to be metabolically inert.
    The process of 5'-monodeiodination that converts T4 to T3, and rT3 to diiodothyronine (DTT) is inhibited in a wide variety of conditions, collectively referred to as nonthyroidal illnesses (NTI) or the 'euthyroid sick' state. These conditions include fasting, malnutrition, poorly controlled diabetes mellitus, trauma, surgery, and systemic illness. Consequently, in patients with NTI the serum T3 level typically decreases, and the rT3 often, but not always, increases.

    Reference Range(s)

    Reverse T3  8-25 ng/dL
    Reverse T3 Takes 7-10 days to get resulted
    		$130
    Complete EBV Panel
    Epstein-Barr Virus (EBV) AB Panel
    Test Details

    Primary infection by EBV causes infectious mononucleosis, usually a self-limiting disease in children and young adults. Infection with EBV can cause lymphoproliferative disorders including tumors. VCA-IgM is typically detectable at clinical presentation, then declines to undetectable levels within a month in young children and within 3 months in other individuals. VCA-IgG is typically detectable at clinical presentation, and persists for life. EBNA IgG typically appears during convalescence (3-4 months after clinical presentation) and remains detectable for life.

    Reference Range(s)

    Epstein-Barr Virus VCA Antibody (IgM)
    U/mLInterpretation
    <36.00Negative
    36.00-43.99Equivocal
    >43.99Positive

    Epstein-Barr Virus VCA Antibody (IgG)
    U/mLInterpretation
    <18.00Negative
    18.00-21.99Equivocal
    >21.99Positive

    Epstein-Barr Virus Nuclear Antigen (EBNA) Antibody (IgG)
    U/mLInterpretation
    <18.00Negative
    18.00-21.99Equivocal
    >21.99Positive

     

    Epstein-Barr Virus Early Antigen D Antibody (IgG)
    Test Details
    Primary infection by EBV causes infectious mononucleosis, usually a self-limiting disease in children and young adults. Infection with EBV can cause lymphoproliferative disorders including tumors. IgG recognizing Early Antigen D typically appears within a month after clinical presentation and is transient, lasting only 3-4 months. Persistently elevated levels suggest reactivation or persistence of EBV infection.

    Reference Range(s)


    U/mLInterpretation
    <9.00Negative
    9.00-10.99Equivocal
    >10.99Positive
    		$83
    Cardiac Health Panel
    Cardiac CRP
    Test Details

    Useful in predicting risk for cardiovascular disease.

    ≤17 yearsNot established
    >17 yearsOptimal <1.0 mg/L

    Jellinger PS et al. Endocr Pract. 2017;23(Suppl 2):1-87.

    For ages >17 years

    hs-CRP (mg/L)Risk According to AHA/CDC Guidelines
    <1.0Lower relative cardiovascular risk.
    1.0-3.0Average relative cardiovascular risk.
    3.1-10.0Higher relative cardiovascular risk. Consider retesting in 1 to 2 weeks to exclude a benign transient elevation in the baseline CRP value secondary to infection or inflammation.
    >10.0Persistent elevation, upon retesting, may be associated with infection and inflammation.
    Homocysteine
    Test Details

    An elevated concentration of homocysteine is an independent risk factor for cardiovascular disease. When used in conjunction with methylmalonic acid (MMA), these tests are useful to diagnose and monitor vitamin B12 (cobalamin) and folic acid deficiency and are often useful in evaluating macrocytosis (an elevated MCV, an erythrocytic index).

    Reference Range(s):

    Male<11.4 umol/L
    Female<10.4 umol/L
    Lipid Panel
    Test Details

    The Lipid Panel includes evaluation of total cholesterol, HDL-cholesterol, triglyceride (TG), LDL-cholesterol (calculated), cholesterol/HDL ratio (calculated), and non-HDL cholesterol. This panel is useful in the detection, classification, and monitoring of hyperlipidemia, especially those expected to have highly elevated TG levels.

    Reference Range(s)

    Total CholesterolMale
    (mg/dL)    		Female
    (mg/dL)
    <20 Years<170<170
    ≥20 Years<200<200
    HDL Cholesterol  
    <20 Years>45>45
    ≥20 Years≥40≥50
    Triglycerides  
    ≤9 Years<75<75
    10-19 Years<90<90
    ≥20 Years<150<150
    LDL-Cholesterol (Calc)  
    <20 Years<110<110
    ≥20 Years<100<100
    Cholesterol/HDL Ratio (Calc)<5.0<5.0
    Non-HDL Cholesterol  
    <20 Years<120<120
    ≥20 Years<130<130

     

    		$88
    Inflammation Panel
    Complete Blood Count (CBC w/DIFF/PLT)
    Test Details

    A complete blood count is used as a screening test for various disease states to include: anemia, leukemia and inflammatory processes.

    Includes:

    • WBC
    • RBC
    • Hemoglobin
    • Hematocrit
    • MCV
    • MCH
    • MCHC
    • RDW
    • Platelet Count
    • MPV and Differential
    • (Absolute and Percent - Neutrophils, Lymphocytes, Monocytes, Eosinophils, and Basophils)


    If abnormal cells are noted on a manual review of the peripheral blood smear or if the automated differential information meets specific criteria, a full manual differential will be performed.

    Sed Rate (ESR)
    Test Details

    Useful in differentiating inflammatory and neoplastic diseases and as an index of disease severity. CRP is also useful in monitoring inflammatory disease states.

     MaleFemale
    ≤50 Years≤15 mm/h≤20 mm/h
    >50 Years≤20 mm/h≤30 mm/h
    C-REACTIVE PROTEIN (CRP)
    Test Details
    Increased CRP levels are found in inflammatory conditions including: bacterial infection, rheumatic fever, active arthritis, myocardial infarction, malignancies and in the post-operative state. This test cannot detect the relatively small elevations of CRP that are associated with increased cardiovascular risk.

    <8.0 mg/L
    Uric Acid
    Test Details

    Serum uric acid measurements are useful in the diagnosis and treatment of numerous renal and metabolic disorders, including renal failure, gout, leukemia, psoriasis, starvation or other wasting conditions, and in patients receiving cytotoxic drugs.

     Male
    (mg/dL)    		Female
    (mg/dL)
    <1 Month

    1.5-3.9

    		1.5-4.6
    1-11 Months1.5-5.61.5-5.4
    1-3 Years2.1-5.61.8-5.0
    4-6 Years1.8-5.52.0-5.1
    7-9 Years1.8-5.41.8-5.5
    10-12 Years2.2-5.82.5-5.9
    13-15 Years3.1-7.02.2-6.4
    16-18 Years2.1-7.62.4-6.6
    ≥19 Years4.0-8.02.5-7.0
    		$78
    Women's Hormone Panel
    Estrogen, Total
    Test Details

    Estrogens are secreted by the gonads, adrenal glands, and placenta. Total estrogens provide an overall picture of estrogen status for men and women.

    Reference Range(s)

    Adult Female 
       Follicular Phase (1-12 days)90-590 pg/mL
       Luteal Phase130-460 pg/mL
       Postmenopausal50-170 pg/mL
    Adult Male60-190 pg/mL
    DHEA-Sulfate
    Test Details

    DHEA-S is the sulfated form of DHEA and is the major androgen produced by the adrenal glands. This test is used in the differential diagnosis of hirsute or virilized female patients and for the diagnosis of isolated premature adrenarche and adrenal tumors. About 10% of hirsute women with Polycystic Ovarian Syndrome (PCOS) have elevated DHEA-S but normal levels of other androgens.

    AgeMale
    (mcg/dL)    		Female
    (mcg/dL)
    <1 Month≤31615-261
    1-6 Months≤58≤74

    7-11 Months

    		≤26≤26
    1-3 Years≤15≤22
    4-6 Years≤27≤34
    7-9 Years≤91≤92
    10-13 Years≤138≤148
    14-17 Years38-34037-307
    18-21 Years24-53751-321
    22-30 Years85-69018-391
    31-40 Years106-46423-266
    41-50 Years70-49519-231
    51-60 Years38-3138-188
    61-70 Years24-24412-133
    ≥71 Years5-2537-177
    FSH & LH
    Test Details

    FSH and LH are secreted by the anterior pituitary in response to gonadotropin-releasing hormone (GNRH) secreted by the hypothalamus. In both males and females, FSH and LH secretion is regulated by a balance of positive and negative feedback mechanisms involving the hypothalamic-pituitary axis, the reproductive organs, and the pituitary and sex steroid hormones. FSH and LH play a critical role in maintaining the normal function of the male and female reproductive systems. Abnormal FSH levels with corresponding increased or decreased levels of LH, estrogens, progesterone, and testosterone are associated with a number of pathological conditions. Increased FSH levels are associated with menopause and primary ovarian hypofunction in females and primary hypogonadism in males. Decreased levels of FSH are associated with primary ovarian hyper-function in females and primary hypergonadism in males. Normal or decreased levels of FSH are associated with polycystic ovary disease in females. In males, LH is also called interstitial cell-stimulating hormone (ICSH). Abnormal LH levels with corresponding increased or decreased levels of FSH, estrogens, progesterone, and testosterone are associated with a number of pathological conditions. Increased LH levels are associated with menopause, primary ovarian hypofunction, and polycystic ovary disease in females and primary hypo-gonadism in males. Decreased LH levels are associated with primary ovarian hyperfunction in females and primary hyper-gonadism in males.

    Reference Range(s)

    FSH
    Male1.6-8.0mIU/mL
    Female  
      Follicular Phase2.5-10.2mIU/mL
      Mid-Cycle Peak3.1-17.7mIU/mL
      Luteal Phase1.5- 9.1mIU/mL
      Postmenopausal  23.0-116.3 mIU/mL

    LH
    Male  
    18-59 Years1.5-9.3mIU/mL
    ≥60 Years1.6-15.2mIU/mL
    Female  
      Follicular Phase1.9-12.5mIU/mL
      Mid-Cycle Peak8.7-76.3mIU/mL
      Luteal Phase0.5-16.9mIU/mL
      Postmenopausal10.0-54.7mIU/mL
    Progesterone
    Test Details

    Levels increase sharply during the luteal phase of the menstrual cycle. The level increases from 9 to 32 weeks of pregnancy.

    Reference Range(s)

    Male<1.4 ng/mL
    Female
    Follicular Phase<1.0 ng/mL
    Luteal Phase2.6-21.5 ng/mL
    Postmenopausal<0.5 ng/mL
    Pregnancy
    First Trimester4.1-34.0 ng/mL
    Second Trimester24.0-76.0 ng/mL
    Third Trimester52.0-302.0 ng/mL
    Children (<18 years old): Progesterone reference ranges established on post-pubertal patient population. Reference range not established for pre-pubertal patients using this assay. For pre-pubertal patients, the Nichols progesterone, LC/MS/MS assay is recommended (test code 17183).
    Testosterone Panel
    Test Details

    Testosterone Panel (Adult), Immunoassay: Due to changes in testosterone levels throughout the day, two morning (8:00-10:00 a.m.) specimens obtained on different days are recommended by The Endocrine Society for screening.

    Reference Range(s)

    Testosterone, Total, (Adult), Immunoassay

    Male250-827 ng/dL
    FemaleNot applicable
    Albumin3.6-5.1 g/dL


    Sex Hormone Binding Globulin

    AgeMale (nmol/L)Female (nmol/L)
    <3 YearsNot establishedNot established
    3-9 Years32-15832-158
    10-13 Years20-16624-120
    14-17 Years20-8712-150
    18-55 Years10-5017-124
    >55 Years22-7714-73


    Free Testosterone

    AgeMale (pg/mL)Female
    18-69 Years46.0-224.0Not applicable
    >69 Years6.0-73.0Not applicable

    Bioavailable Testosterone

    AgeMale (ng/dL)Female
    18-69 Years110.0-575.0Not applicable
    >69 Years15.0-150.0Not applicable
    Cortisol, Total
    Test Details

    Cortisol is increased in Cushing's Disease and decreased in Addison's Disease (adrenal insufficiency).

    0-3 Days (infants)
    Premature (31-35 Weeks)a.m. or p.m. ≤15.0 mcg/dL
    Terma.m. or p.m. ≤14.0 mcg/dL
    4 Days-1 Montha.m. or p.m. Not established
    2-11 Monthsa.m. 3.0-23.0 mcg/dL
    p.m. Not established
    1-17 Yearsa.m. 3.0-25.0 mcg/dL
    p.m. 3.0-17.0 mcg/dL
    Adult 8 a.m. (7-9 a.m.) specimen4.0-22.0 mcg/dL
    Adult 4 p.m. (3-5 p.m.) specimen3.0-17.0 mcg/dL
    		$176
    Women's Health Panel
    Complete Metabolic Panel (CMP)
    Test Details

    • Albumin
    • Albumin/Globulin Ratio (calculated)
    • Alkaline Phosphatase
    • ALT
    • AST
    • BUN/Creatinine Ratio (calculated)
    • Calcium
    • Carbon Dioxide
    • Chloride
    • Creatinine with GFR Estimated
    • Globulin (calculated)
    • Glucose
    • Potassium
    • Sodium
    • Total Bilirubin
    • Total Protein
    • Urea Nitrogen
    Hemoglobin A1c
    Test Details
    To assist with control of blood glucose levels, the American Diabetes Association (ADA) has recommended glycated hemoglobin testing (HbA1c) twice a year for patients with stable glycemia, and quarterly for patients with poor glucose control. Interpretative ranges are based on ADA guidelines.

    Reference Range(s)

    <5.7 % of total hemoglobin
    Complete Blood Count (CBC w/DIFF/PLT)
    Test Details

    A complete blood count is used as a screening test for various disease states to include: anemia, leukemia and inflammatory processes.

    Includes:

    • WBC
    • RBC
    • Hemoglobin
    • Hematocrit
    • MCV
    • MCH
    • MCHC
    • RDW
    • Platelet Count
    • MPV and Differential
    • (Absolute and Percent - Neutrophils, Lymphocytes, Monocytes, Eosinophils, and Basophils)


    If abnormal cells are noted on a manual review of the peripheral blood smear or if the automated differential information meets specific criteria, a full manual differential will be performed.

    Lipid Panel
    Test Details

    The Lipid Panel includes evaluation of total cholesterol, HDL-cholesterol, triglyceride (TG), LDL-cholesterol (calculated), cholesterol/HDL ratio (calculated), and non-HDL cholesterol. This panel is useful in the detection, classification, and monitoring of hyperlipidemia, especially those expected to have highly elevated TG levels.

    Reference Range(s)

    Total CholesterolMale
    (mg/dL)    		Female
    (mg/dL)
    <20 Years<170<170
    ≥20 Years<200<200
    HDL Cholesterol  
    <20 Years>45>45
    ≥20 Years≥40≥50
    Triglycerides  
    ≤9 Years<75<75
    10-19 Years<90<90
    ≥20 Years<150<150
    LDL-Cholesterol (Calc)  
    <20 Years<110<110
    ≥20 Years<100<100
    Cholesterol/HDL Ratio (Calc)<5.0<5.0
    Non-HDL Cholesterol  
    <20 Years<120<120
    ≥20 Years<130<130

     

    Magnesium
    Test Details
    Magnesium measurements are used in the diagnosis and treatment of hypomagnesemia (abnormally low plasma levels of magnesium) and hypermagnesemia (abnormally high plasma levels of magnesium). Magnesium is decreased in chronic nephritis, acute pancreatitis, and alcoholic cirrhosis. It is increased in acute or chronic renal failure and Addison's Disease.

    Reference Range(s)

    1.5-2.5 mg/dL
    Uric Acid
    Test Details

    Serum uric acid measurements are useful in the diagnosis and treatment of numerous renal and metabolic disorders, including renal failure, gout, leukemia, psoriasis, starvation or other wasting conditions, and in patients receiving cytotoxic drugs.

     Male
    (mg/dL)    		Female
    (mg/dL)
    <1 Month

    1.5-3.9

    		1.5-4.6
    1-11 Months1.5-5.61.5-5.4
    1-3 Years2.1-5.61.8-5.0
    4-6 Years1.8-5.52.0-5.1
    7-9 Years1.8-5.41.8-5.5
    10-12 Years2.2-5.82.5-5.9
    13-15 Years3.1-7.02.2-6.4
    16-18 Years2.1-7.62.4-6.6
    ≥19 Years4.0-8.02.5-7.0
    Iron, Total and TIBC
    Test Details

    Serum iron quantification is useful in confirming the diagnosis of iron-deficiency anemia or hemochromatosis. The measurement of total iron binding in the same specimen may facilitate the clinician's ability to distinguish between low serum iron levels caused by iron deficiency from those related to inflammatory neoplastic disorders. The assay for iron measures the amount of iron which is bound to transferrin. The total iron binding capacity (TIBC) measures the amount of iron that would appear in blood if all the transferrin were saturated with iron. It is an indirect measurement of transferrin concentrations but expressed as an iron measurement. To obtain the percent saturation, the serum iron is divided by the TIBC which gives the actual amount of saturated transferrin. The percent saturation is low in iron deficiency and high in iron storage diseases.

    Reference Range(s):

    Iron, Total

    Age    		Male
    (mcg/dL)    		Female
    (mcg/dL)
    <1 Month32-11229-127
    1-11 Months27-10925-126
    1-3 Years29-9125-101
    4-19 Years27-16427-164
    20-29 Years50-19540-190
    30-49 Years50-18040-190
    ≥50 Years50-18045-160

    Iron Binding Capacity

    Age    		Male
    mcg/dL (calc)    		Female
    mcg/dL (calc)
    <1 Month94-23294-236
    1-5 Months116-32289-311
    6-11 Months176-384138-365
    1-19 Years271-448271-448
    ≥20 Years250-425250-450

    % Saturation

    Age    		Male
    % (calc)    		Female
    % (calc)
    <1 Year10-4812-45
    1-12 Years12-4813-45
    13-19 Years16-4815-45
    ≥20 Years20-4816-45
    Gamma Glutamyl Transferase (GGT)
    Test Details

    Elevated GGT is found in all forms of liver disease. Measurement of GGT is used in the diagnosis and treatment of alcoholic cirrhosis, as well as primary and secondary liver tumors. It is more sensitive than alkaline phosphatase, the transaminases, and leucine aminopeptidase in detecting obstructive jaundice, cholangitis, and cholecystitis. Normal levels of GGT are seen in skeletal diseases; thus, GGT in serum can be used to ascertain whether a disease, suggested by elevated alkaline phosphatase, is skeletal or hepatobiliary.

    Reference Range(s)

    Male (U/L)Female (U/L)
    <6 Months12-12215-132
    6-11 Months ≤39 ≤39
    1-12 Years3-223-22
    13-15 Years8-327-18
    16-19 Years9-316-26
    20-29 Years3-703-40
    30-39 Years3-903-50
    40-54 Years3-95 
    40-49 Years 3-55
    50-59 Years 3-70
    55-59 Years3-85 
    ≥60 Years3-703-65
    Estrogen, Total
    Test Details

    Estrogens are secreted by the gonads, adrenal glands, and placenta. Total estrogens provide an overall picture of estrogen status for men and women.

    Reference Range(s)

    Adult Female 
       Follicular Phase (1-12 days)90-590 pg/mL
       Luteal Phase130-460 pg/mL
       Postmenopausal50-170 pg/mL
    Adult Male60-190 pg/mL
    DHEA-Sulfate
    Test Details

    DHEA-S is the sulfated form of DHEA and is the major androgen produced by the adrenal glands. This test is used in the differential diagnosis of hirsute or virilized female patients and for the diagnosis of isolated premature adrenarche and adrenal tumors. About 10% of hirsute women with Polycystic Ovarian Syndrome (PCOS) have elevated DHEA-S but normal levels of other androgens.

    AgeMale
    (mcg/dL)    		Female
    (mcg/dL)
    <1 Month≤31615-261
    1-6 Months≤58≤74

    7-11 Months

    		≤26≤26
    1-3 Years≤15≤22
    4-6 Years≤27≤34
    7-9 Years≤91≤92
    10-13 Years≤138≤148
    14-17 Years38-34037-307
    18-21 Years24-53751-321
    22-30 Years85-69018-391
    31-40 Years106-46423-266
    41-50 Years70-49519-231
    51-60 Years38-3138-188
    61-70 Years24-24412-133
    ≥71 Years5-2537-177
    FSH & LH
    Test Details

    FSH and LH are secreted by the anterior pituitary in response to gonadotropin-releasing hormone (GNRH) secreted by the hypothalamus. In both males and females, FSH and LH secretion is regulated by a balance of positive and negative feedback mechanisms involving the hypothalamic-pituitary axis, the reproductive organs, and the pituitary and sex steroid hormones. FSH and LH play a critical role in maintaining the normal function of the male and female reproductive systems. Abnormal FSH levels with corresponding increased or decreased levels of LH, estrogens, progesterone, and testosterone are associated with a number of pathological conditions. Increased FSH levels are associated with menopause and primary ovarian hypofunction in females and primary hypogonadism in males. Decreased levels of FSH are associated with primary ovarian hyper-function in females and primary hypergonadism in males. Normal or decreased levels of FSH are associated with polycystic ovary disease in females. In males, LH is also called interstitial cell-stimulating hormone (ICSH). Abnormal LH levels with corresponding increased or decreased levels of FSH, estrogens, progesterone, and testosterone are associated with a number of pathological conditions. Increased LH levels are associated with menopause, primary ovarian hypofunction, and polycystic ovary disease in females and primary hypo-gonadism in males. Decreased LH levels are associated with primary ovarian hyperfunction in females and primary hyper-gonadism in males.

    Reference Range(s)

    FSH
    Male1.6-8.0mIU/mL
    Female  
      Follicular Phase2.5-10.2mIU/mL
      Mid-Cycle Peak3.1-17.7mIU/mL
      Luteal Phase1.5- 9.1mIU/mL
      Postmenopausal  23.0-116.3 mIU/mL

    LH
    Male  
    18-59 Years1.5-9.3mIU/mL
    ≥60 Years1.6-15.2mIU/mL
    Female  
      Follicular Phase1.9-12.5mIU/mL
      Mid-Cycle Peak8.7-76.3mIU/mL
      Luteal Phase0.5-16.9mIU/mL
      Postmenopausal10.0-54.7mIU/mL
    Progesterone
    Test Details

    Levels increase sharply during the luteal phase of the menstrual cycle. The level increases from 9 to 32 weeks of pregnancy.

    Reference Range(s)

    Male<1.4 ng/mL
    Female
    Follicular Phase<1.0 ng/mL
    Luteal Phase2.6-21.5 ng/mL
    Postmenopausal<0.5 ng/mL
    Pregnancy
    First Trimester4.1-34.0 ng/mL
    Second Trimester24.0-76.0 ng/mL
    Third Trimester52.0-302.0 ng/mL
    Children (<18 years old): Progesterone reference ranges established on post-pubertal patient population. Reference range not established for pre-pubertal patients using this assay. For pre-pubertal patients, the Nichols progesterone, LC/MS/MS assay is recommended (test code 17183).
    Vitamin D, 25-Hydroxy
    Test Details
    Measurement of serum 25-OH vitamin D concentrations provide a good index of circulating vitamin D activity in patients not suffering from renal disease. Lower than normal 25-OH vitamin D levels can result from a dietary deficiency, poor absorption of the vitamin or impaired metabolism of the sterol in the liver. A 25-OH vitamin D deficiency can lead to bone diseases such as rickets and osteomalacia. Above normal levels can lead to hypercalcemia.  Fasting preferred but not required

    30-100 ng/mL
    Thyroid Panel w/TSH
    Test Details

    Thyroid Panel: T3 Uptake, T4 (Thyroxine) Total, Free T4 Index (T7)
    TSH

    Reference Range(s)

    T3 Uptake:    22-35.5%,

    Decreased: Pregnancy, estrogens, hyperproteinemia, acute intermittent porphyria.
    Increased: Androgens, hyperproteinemia, stress, acute liver disease.

    T4 (Thyroxine) Total:  

    For diagnosis of hypothyroidism and hyperthyroidism.

    Male (mcg/dL)Female (mcg/dL)
    <1 Month4.5-17.24.5-17.2
    1-23 Months5.9-13.95.9-13.9
    2-12 Years5.7-11.65.7-11.6
    13-20 Years5.1-10.35.3-11.7
    >20 Years4.9-10.55.1-11.9

     

    Free T4 Index (T7)1.4-3.8

    TSH

    For differential diagnosis of primary, secondary, and tertiary hypothyroidism. Also useful in screening for hyperthyroidism. This assay allows adjustment of exogenous thyroxine dosage in hypothyroid patients and in patients on suppressive thyroxine therapy for thyroid neoplasia.

    Premature Infants (28-36 Weeks) 
      1st Week of Life0.20-27.90 mIU/L
    Term Infants (>37 Weeks) 
      Serum or Cord Blood1.00-39.00 mIU/L
      1-2 Days3.20-34.60 mIU/L
      3-4 Days0.70-15.40 mIU/L
      5 Days-4 Weeks1.70-9.10 mIU/L
      1-11 Months0.80-8.20 mIU/L
      1-19 Years0.50-4.30 mIU/L
      ≥20 Years0.40-4.50 mIU/L
    Pregnancy 
      First Trimester0.26-2.66 mIU/L
      Second Trimester0.55-2.73 mIU/L
      Third Trimester0.43-2.91 mIU/L
    Homocysteine
    Test Details

    An elevated concentration of homocysteine is an independent risk factor for cardiovascular disease. When used in conjunction with methylmalonic acid (MMA), these tests are useful to diagnose and monitor vitamin B12 (cobalamin) and folic acid deficiency and are often useful in evaluating macrocytosis (an elevated MCV, an erythrocytic index).

    Reference Range(s):

    Male<11.4 umol/L
    Female<10.4 umol/L
    		$315
    Men's Hormone Panel
    PSA, total
    Test Details

    Elevated serum PSA concentrations have been reported in men with prostate cancer, benign prostatic hypertrophy, and inflammatory conditions of the prostate.

    Reference Range(s)

    Male≤4.0 ng/mL
    FemaleNot established
    Testosterone Panel
    Test Details

    Testosterone, Total, Males (Adult), Immunoassay: Due to changes in testosterone levels throughout the day, two morning (8:00-10:00 a.m.) specimens obtained on different days are recommended by The Endocrine Society for screening.

    Reference Range(s)

    Testosterone, Total, Males (Adult), Immunoassay

    Male250-827 ng/dL
    FemaleNot applicable

    Albumin3.6-5.1 g/dL


    Sex Hormone Binding Globulin

    AgeMale (nmol/L)Female (nmol/L)
    <3 YearsNot establishedNot established
    3-9 Years32-15832-158
    10-13 Years20-16624-120
    14-17 Years20-8712-150
    18-55 Years10-5017-124
    >55 Years22-7714-73


    Free Testosterone

    AgeMale (pg/mL)Female
    18-69 Years46.0-224.0Not applicable
    >69 Years6.0-73.0Not applicable

    Bioavailable Testosterone

    AgeMale (ng/dL)Female
    18-69 Years110.0-575.0Not applicable
    >69 Years15.0-150.0Not applicable
    DHEA-Sulfate
    Test Details

    DHEA-S is the sulfated form of DHEA and is the major androgen produced by the adrenal glands. This test is used in the differential diagnosis of hirsute or virilized female patients and for the diagnosis of isolated premature adrenarche and adrenal tumors. About 10% of hirsute women with Polycystic Ovarian Syndrome (PCOS) have elevated DHEA-S but normal levels of other androgens.

    AgeMale
    (mcg/dL)    		Female
    (mcg/dL)
    <1 Month≤31615-261
    1-6 Months≤58≤74

    7-11 Months

    		≤26≤26
    1-3 Years≤15≤22
    4-6 Years≤27≤34
    7-9 Years≤91≤92
    10-13 Years≤138≤148
    14-17 Years38-34037-307
    18-21 Years24-53751-321
    22-30 Years85-69018-391
    31-40 Years106-46423-266
    41-50 Years70-49519-231
    51-60 Years38-3138-188
    61-70 Years24-24412-133
    ≥71 Years5-2537-177
    		$94
    Men's Health Panel
    Complete Metabolic Panel (CMP)
    Test Details

    • Albumin
    • Albumin/Globulin Ratio (calculated)
    • Alkaline Phosphatase
    • ALT
    • AST
    • BUN/Creatinine Ratio (calculated)
    • Calcium
    • Carbon Dioxide
    • Chloride
    • Creatinine with GFR Estimated
    • Globulin (calculated)
    • Glucose
    • Potassium
    • Sodium
    • Total Bilirubin
    • Total Protein
    • Urea Nitrogen
    Hemoglobin A1c
    Test Details
    To assist with control of blood glucose levels, the American Diabetes Association (ADA) has recommended glycated hemoglobin testing (HbA1c) twice a year for patients with stable glycemia, and quarterly for patients with poor glucose control. Interpretative ranges are based on ADA guidelines.

    Reference Range(s)

    <5.7 % of total hemoglobin
    Complete Blood Count (CBC w/DIFF/PLT)
    Test Details

    A complete blood count is used as a screening test for various disease states to include: anemia, leukemia and inflammatory processes.

    Includes:

    • WBC
    • RBC
    • Hemoglobin
    • Hematocrit
    • MCV
    • MCH
    • MCHC
    • RDW
    • Platelet Count
    • MPV and Differential
    • (Absolute and Percent - Neutrophils, Lymphocytes, Monocytes, Eosinophils, and Basophils)


    If abnormal cells are noted on a manual review of the peripheral blood smear or if the automated differential information meets specific criteria, a full manual differential will be performed.

    Lipid Panel
    Test Details

    The Lipid Panel includes evaluation of total cholesterol, HDL-cholesterol, triglyceride (TG), LDL-cholesterol (calculated), cholesterol/HDL ratio (calculated), and non-HDL cholesterol. This panel is useful in the detection, classification, and monitoring of hyperlipidemia, especially those expected to have highly elevated TG levels.

    Reference Range(s)

    Total CholesterolMale
    (mg/dL)    		Female
    (mg/dL)
    <20 Years<170<170
    ≥20 Years<200<200
    HDL Cholesterol  
    <20 Years>45>45
    ≥20 Years≥40≥50
    Triglycerides  
    ≤9 Years<75<75
    10-19 Years<90<90
    ≥20 Years<150<150
    LDL-Cholesterol (Calc)  
    <20 Years<110<110
    ≥20 Years<100<100
    Cholesterol/HDL Ratio (Calc)<5.0<5.0
    Non-HDL Cholesterol  
    <20 Years<120<120
    ≥20 Years<130<130

     

    Magnesium
    Test Details
    Magnesium measurements are used in the diagnosis and treatment of hypomagnesemia (abnormally low plasma levels of magnesium) and hypermagnesemia (abnormally high plasma levels of magnesium). Magnesium is decreased in chronic nephritis, acute pancreatitis, and alcoholic cirrhosis. It is increased in acute or chronic renal failure and Addison's Disease.

    Reference Range(s)

    1.5-2.5 mg/dL
    TSH
    Test Details

    For differential diagnosis of primary, secondary, and tertiary hypothyroidism. Also useful in screening for hyperthyroidism. This assay allows adjustment of exogenous thyroxine dosage in hypothyroid patients and in patients on suppressive thyroxine therapy for thyroid neoplasia.

    Premature Infants (28-36 Weeks) 
      1st Week of Life0.20-27.90 mIU/L
    Term Infants (>37 Weeks) 
      Serum or Cord Blood1.00-39.00 mIU/L
      1-2 Days3.20-34.60 mIU/L
      3-4 Days0.70-15.40 mIU/L
      5 Days-4 Weeks1.70-9.10 mIU/L
      1-11 Months0.80-8.20 mIU/L
      1-19 Years0.50-4.30 mIU/L
      ≥20 Years0.40-4.50 mIU/L
    Pregnancy 
      First Trimester0.26-2.66 mIU/L
      Second Trimester0.55-2.73 mIU/L
      Third Trimester0.43-2.91 mIU/L
    Uric Acid
    Test Details

    Serum uric acid measurements are useful in the diagnosis and treatment of numerous renal and metabolic disorders, including renal failure, gout, leukemia, psoriasis, starvation or other wasting conditions, and in patients receiving cytotoxic drugs.

     Male
    (mg/dL)    		Female
    (mg/dL)
    <1 Month

    1.5-3.9

    		1.5-4.6
    1-11 Months1.5-5.61.5-5.4
    1-3 Years2.1-5.61.8-5.0
    4-6 Years1.8-5.52.0-5.1
    7-9 Years1.8-5.41.8-5.5
    10-12 Years2.2-5.82.5-5.9
    13-15 Years3.1-7.02.2-6.4
    16-18 Years2.1-7.62.4-6.6
    ≥19 Years4.0-8.02.5-7.0
    Iron, Total and TIBC
    Test Details

    Serum iron quantification is useful in confirming the diagnosis of iron-deficiency anemia or hemochromatosis. The measurement of total iron binding in the same specimen may facilitate the clinician's ability to distinguish between low serum iron levels caused by iron deficiency from those related to inflammatory neoplastic disorders. The assay for iron measures the amount of iron which is bound to transferrin. The total iron binding capacity (TIBC) measures the amount of iron that would appear in blood if all the transferrin were saturated with iron. It is an indirect measurement of transferrin concentrations but expressed as an iron measurement. To obtain the percent saturation, the serum iron is divided by the TIBC which gives the actual amount of saturated transferrin. The percent saturation is low in iron deficiency and high in iron storage diseases.

    Reference Range(s):

    Iron, Total

    Age    		Male
    (mcg/dL)    		Female
    (mcg/dL)
    <1 Month32-11229-127
    1-11 Months27-10925-126
    1-3 Years29-9125-101
    4-19 Years27-16427-164
    20-29 Years50-19540-190
    30-49 Years50-18040-190
    ≥50 Years50-18045-160

    Iron Binding Capacity

    Age    		Male
    mcg/dL (calc)    		Female
    mcg/dL (calc)
    <1 Month94-23294-236
    1-5 Months116-32289-311
    6-11 Months176-384138-365
    1-19 Years271-448271-448
    ≥20 Years250-425250-450

    % Saturation

    Age    		Male
    % (calc)    		Female
    % (calc)
    <1 Year10-4812-45
    1-12 Years12-4813-45
    13-19 Years16-4815-45
    ≥20 Years20-4816-45
    Gamma Glutamyl Transferase (GGT)
    Test Details

    Elevated GGT is found in all forms of liver disease. Measurement of GGT is used in the diagnosis and treatment of alcoholic cirrhosis, as well as primary and secondary liver tumors. It is more sensitive than alkaline phosphatase, the transaminases, and leucine aminopeptidase in detecting obstructive jaundice, cholangitis, and cholecystitis. Normal levels of GGT are seen in skeletal diseases; thus, GGT in serum can be used to ascertain whether a disease, suggested by elevated alkaline phosphatase, is skeletal or hepatobiliary.

    Reference Range(s)

    Male (U/L)Female (U/L)
    <6 Months12-12215-132
    6-11 Months ≤39 ≤39
    1-12 Years3-223-22
    13-15 Years8-327-18
    16-19 Years9-316-26
    20-29 Years3-703-40
    30-39 Years3-903-50
    40-54 Years3-95 
    40-49 Years 3-55
    50-59 Years 3-70
    55-59 Years3-85 
    ≥60 Years3-703-65
    PSA, total
    Test Details

    Elevated serum PSA concentrations have been reported in men with prostate cancer, benign prostatic hypertrophy, and inflammatory conditions of the prostate.

    Reference Range(s)

    Male≤4.0 ng/mL
    FemaleNot established
    DHEA-SULFATE
    Test Details

    DHEA-S is the sulfated form of DHEA and is the major androgen produced by the adrenal glands. This test is used in the differential diagnosis of hirsute or virilized female patients and for the diagnosis of isolated premature adrenarche and adrenal tumors. About 10% of hirsute women with Polycystic Ovarian Syndrome (PCOS) have elevated DHEA-S but normal levels of other androgens.

    AgeMale
    (mcg/dL)    		Female
    (mcg/dL)
    <1 Month≤31615-261
    1-6 Months≤58≤74

    7-11 Months

    		≤26≤26
    1-3 Years≤15≤22
    4-6 Years≤27≤34
    7-9 Years≤91≤92
    10-13 Years≤138≤148
    14-17 Years38-34037-307
    18-21 Years24-53751-321
    22-30 Years85-69018-391
    31-40 Years106-46423-266
    41-50 Years70-49519-231
    51-60 Years38-3138-188
    61-70 Years24-24412-133
    ≥71 Years5-2537-177
    Vitamin D, 25-Hydroxy
    Test Details
    Measurement of serum 25-OH vitamin D concentrations provide a good index of circulating vitamin D activity in patients not suffering from renal disease. Lower than normal 25-OH vitamin D levels can result from a dietary deficiency, poor absorption of the vitamin or impaired metabolism of the sterol in the liver. A 25-OH vitamin D deficiency can lead to bone diseases such as rickets and osteomalacia. Above normal levels can lead to hypercalcemia.  Fasting preferred but not required

    30-100 ng/mL
    Homocysteine
    Test Details

    An elevated concentration of homocysteine is an independent risk factor for cardiovascular disease. When used in conjunction with methylmalonic acid (MMA), these tests are useful to diagnose and monitor vitamin B12 (cobalamin) and folic acid deficiency and are often useful in evaluating macrocytosis (an elevated MCV, an erythrocytic index).

    Reference Range(s):

    Male<11.4 umol/L
    Female<10.4 umol/L
    Cardiac CRP
    Test Details

    Useful in predicting risk for cardiovascular disease.

    ≤17 yearsNot established
    >17 yearsOptimal <1.0 mg/L

    Jellinger PS et al. Endocr Pract. 2017;23(Suppl 2):1-87.

    For ages >17 years

    hs-CRP (mg/L)Risk According to AHA/CDC Guidelines
    <1.0Lower relative cardiovascular risk.
    1.0-3.0Average relative cardiovascular risk.
    3.1-10.0Higher relative cardiovascular risk. Consider retesting in 1 to 2 weeks to exclude a benign transient elevation in the baseline CRP value secondary to infection or inflammation.
    >10.0Persistent elevation, upon retesting, may be associated with infection and inflammation.
    		$238